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Abstract
Researcher:

Daniel Mark Bull

Title:

The Effects of Energy Beverages in Counteracting the Symptoms of Mild
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Institution:
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Degree:
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Year:

2012

The purpose of this thesis was to conduct preliminary research, in the form of a pilot
study, concerning the natural effects of hypoxia compared to the effects of hypoxia
experienced after the consumption of an energy beverage. The study evaluated the effects
of hypoxia on FAA certificated pilots at a simulated legal general aviation altitude,
utilizing the normobaric High Altitude Lab (HAL) located at Embry Riddle Aeronautical
University, Daytona Beach, Florida. The researcher tested 11 subjects, who completed
three simulated flight tasks within the HAL using the Frasca International Mentor
Advanced Aviation Training Device (AATD). The flight tasks were completed after
consuming Red Bull®, Monster®, or a placebo beverage. The researcher derived three test
variables from core outputs of the AATD: lateral deviations from the glide slope, vertical
deviations from the localizer, and airspeed deviations from the target speed of 100 knots.
A repeated-measures ANOVA was carried out to determine effects of the beverages on
the test variables. While results were non-significant, the researcher concluded that
further research should be conducted with a larger sample.

iv

Table of Contents
Page
Thesis Review Committee .................................................................................................. ii
Acknowledgements ............................................................................................................ iii
Abstract .............................................................................................................................. iv
List of Tables ................................................................................................................... viii
List of Figures ......................................................................................................................x
Chapter
I

Introduction ..................................................................................................1
Significance of the Study .................................................................3
Statement of the Problem .................................................................4
Purpose Statement ............................................................................5
Hypothesis........................................................................................5
Delimitations ....................................................................................6
Limitations and Assumptions ..........................................................6
Definitions of Terms ........................................................................7
List of Acronyms .............................................................................8

II

Review of the Relevant Literature .............................................................10
FAA Regulations ...........................................................................10
Hypoxia ..........................................................................................12
Symptoms of Hypoxia .......................................................13
Energy and Sports Beverages ........................................................17
Core Active Ingredients in Energy Beverages ...................18

v

Effects of Energy Beverages ..............................................20
Normobaric High Altitude Lab ......................................................23
Frasca International Mentor Advanced Aviation Training
Device ............................................................................................24
Pulse Oximeter ...............................................................................24
Summary ........................................................................................25
III

Methodology ..............................................................................................28
Research Approach ........................................................................28
Design and Procedures .......................................................29
Apparatus and Materials ....................................................30
Instrument Pre Test ........................................................................31
Subjects ..........................................................................................31
Sources of the Data ........................................................................32
Instrument Reliability ........................................................32
Instrument Validity ............................................................33
Treatment of the Data ....................................................................33
Descriptive Statistics ..........................................................33
Hypothesis Testing.............................................................34
Pilot Study......................................................................................34

IV

Results ........................................................................................................35
Descriptive Statistics - Pre-Test Questionnaire .............................35
Descriptive Statistics - Pulse Oximeter Readings ..........................44
Descriptive Statistics - AATD Performance Output ......................45
Hypothesis Testing.........................................................................47

vi

Approach Plate Related to Simulated Flight Task
Performance .......................................................................47
Energy Beverage Related to Simulated Flight Task
Performance .......................................................................49
V

Discussion, Conclusions, and Recommendations ......................................52
Discussion ......................................................................................52
Localizer Deviations ..........................................................52
Glide-Slope Deviations ......................................................53
Indicated Airspeed Deviations ...........................................54
Pulse Oximeter .......................................................55
Conclusions ....................................................................................56
Recommendations ..........................................................................58

References ..........................................................................................................................60
Appendices
A

Permission to Conduct Research ...............................................................65

B

Pre Test Survey ..........................................................................................67

C

HAL Medical Screening and Release Forms .............................................70

D

HAL Setup Procedures ..............................................................................75

E

Tables .........................................................................................................82

vii

List of Tables
Page
Table
1

Symptoms of Hypoxia ...........................................................................................15

2

Descriptive Statistics for Question 2......................................................................35

3

Descriptive Statistics for Question 11....................................................................40

4

Descriptive Statistics for Question 19....................................................................43

5

Descriptive Statistics for Pre/Post-Test BPM Recordings .....................................44

6

Descriptive Statistics for Pre/Post-Test %SpO2 Recordings .................................45

7

Descriptive Statistics Displaying AATD Outputs for Gainesville, Jacksonville,
or St. Augustine .....................................................................................................46

8

Descriptive Statistics Displaying AATD Outputs for Red Bull®, Monster®, or a
Placebo ...................................................................................................................47

9

Repeated-Measures ANOVA Comparing Localizer Deviation Between
Approaches ............................................................................................................48

10 Repeated-Measures ANOVA Comparing Glide-Slope Deviation Between
Approaches ............................................................................................................48
11 Repeated-Measures ANOVA Comparing Indicated Airspeed Deviation Between
Approaches ............................................................................................................49
12 Repeated-Measures ANOVA Comparing Localizer Deviation Between Beverages
................................................................................................................................50
13 Repeated-Measures ANOVA Comparing Glide-Slope Deviation Between
Beverages ...............................................................................................................50
14 Repeated-Measures ANOVA Comparing Indicated Airspeed Deviation Between
Beverages ...............................................................................................................51
15 AATD Output Means for Gainesville ...................................................................83
16 AATD Output Means for Jacksonville...................................................................83
17 AATD Output Means for St. Augustine ..................................................................84

viii

18 AATD Output Means for Red Bull® .......................................................................84
19 AATD Output Means for Monster® ........................................................................85
20 AATD Output Means for Placebo ...........................................................................85

ix

List of Figures
Page
Figure
1

Question #1 ............................................................................................................35

2

Question #4 ............................................................................................................36

3

Question #5 ............................................................................................................37

4

Question #6 ............................................................................................................37

5

Question #7 ............................................................................................................38

6

Question #8 ............................................................................................................38

7

Question #9 ............................................................................................................39

8

Question #10 ..........................................................................................................39

9

Question #12 ..........................................................................................................40

10 Question #13 ..........................................................................................................41
11 Question #14 ..........................................................................................................41
12 Question #15………………… ..............................................................................42
13 Question #16 ..........................................................................................................42
14 Question #17 ..........................................................................................................43

x

1
Chapter I
Introduction
Since the beginning of time, humans have been fascinated with the miracle of
flight. As humankind has developed and technology has advanced, there has been
continued pressure to go faster, make aircraft stronger, and fly aircraft higher.
Humankind is obsessed with pushing machinery to its limits in the name of science,
education and discovery. In the voyage of discovery, humankind has celebrated
achievements in obtaining the best results possible from, not only ourselves, but also our
creations (Dempsey & Gesell, 2010).
In this study, the researcher recognized that, as technologically advanced aircraft
are accessible to a greater number of General Aviation (GA) pilots, it is increasingly
possible to operate aircraft that are able to achieve altitudes greater than ever before. The
Federal Aviation Administration (FAA) states that there is a positive correlation between
altitude and fuel consumption (Federal Aviation Administration [FAA], 2012). Therefore,
pilots would naturally climb to the highest altitude possible to experience the best
possible performance from their aircraft. The legal limit to which a GA pilot may climb
without supplementary oxygen is 14,000 feet above mean sea level (MSL) (Certification:
Pilots, Flight Instructors, and Ground Instructors Rule, 2010).
FAA (2011) also notes that at altitudes as low as 5,000 feet MSL, a pilot may
experience symptoms of hypoxia. Altitude-hypoxia is a condition that occurs in the body
due to the reduction of air pressure as altitude increases. As a result, there is a reduction
in the body’s efficiency to absorb oxygen (FAA, 2011). Darwish (2003) states that the
symptoms of hypoxia can be classified into five stages, which relate to the saturation of
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oxygen found in the body in correlation with increasing altitude. Symptoms can range
from reduced night-vision in low-altitude hypoxia, to a worst-case scenario of
cardiovascular collapse in high-altitude hypoxia (Darwish, 2003). However, each
individual has his or her own tolerances to hypoxia, which can result in different levels of
severity of symptoms (Darwish, 2003).
Low-altitude hypoxia, as defined by Darwish (2003), is also noted by FAA (2011)
to occur between “12,000 to 15,000 feet MSL of altitude” in which “judgment, memory
alertness, coordination and ability to make calculations are impaired, and headache,
drowsiness, dizziness and either a sense of well being (euphoria) or belligerence occur”
(p. 922). The researcher conducted an interview regarding low-altitude hypoxia with Dr.
C. Howell, an expert in Aviation Human Factors, Human Physiology, Aviation Safety,
Crew Resource Management, Situational Awareness, and NextGen General Aircraft
(Embry-Riddle Aeronautical University [ERAU], 2012). Dr. C. Howell suggested that
energy beverages could potentially reduce the symptoms experienced in a low-altitude,
hypoxic environment. He based this statement on his personal observations noted when
flying his own aircraft at the upper legal limits (Dr. C. Howell, personal communication,
November 15, 2010). Energy beverages have a range of active ingredients, which have
been reputed to improve mental focus, increase oxygen intake, and improve alertness
(Smit & Rogers, 2002). The researcher was interested in discovering whether energy
beverages could have an effect on a pilot when in a low-oxygen environment.
Through the compulsory education required in achieving any level of pilot
qualification, pilots should be aware of all elements of hypoxia. However, many pilots
may be unaware of the severity of the dangers found in the symptoms of hypoxia. The
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guidelines surrounding altitudes where hypoxia may occur are diverse and often
inconsistent, even among the publications produced by the regulatory control bodies.
The researcher was interested in whether consuming an energy beverage before flight
could result in a reduction of the symptoms of hypoxia at altitudes where there is
potential for hypoxia.
Significance of the Study
This study holds great importance, as currently the only mention of beverages as
prescribed for GA pilots by the US government concerning alcohol consumption (FAA,
2011). This study covered areas of research where the outcome could be significant for
pilots, the FAA, and Aero-Medical boards. Therefore, the study could produce a safety
recommendation for pilots to take precautions against the symptoms of hypoxia through
the consumption of an energy beverage.
The rules published by the FAA suggest that GA pilots may fly as high as 12,500
feet MSL any time, and up to 14,000 feet MSL for 30 minutes, without a requirement for
supplementary oxygen (Supplemental Oxygen Rule, 2010). However, the FAA also
states that the effects of hypoxia can be present at an altitude of 5,000 feet MSL at night
(FAA, 2011). Therefore, it is important that pilots can recognize hypoxia, the potential
dangers, and possible ways of counteracting its symptoms. Research suggests that
hypoxia can affect individuals differently, depending on their individual tolerances and
general condition of health (Darwish, 2003). The variable factors are smoking, weight,
alcohol consumption, fitness, and prescribed medication (FAR, 2011).
It was noted by an experienced pilot that there was an observed decrease in the
recognized effects of hypoxia from flying at altitudes between 10,000 and 14,000 feet
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MSL when consuming an energy beverage before flight. Upon further exploration it was
discovered that the positive effects of energy beverages have been evaluated in scenarios
related to driving (Mets et al., 2010), concentration (Smit & Rogers, 2002), and in
research on armed forces personnel, but not in relation to flying (Tharion, Montain,
O'Brien, Shippee, & Hoban, 1997). Since there has been no research regarding energy
beverages and low-altitude hypoxia, the researcher believed there was an opportunity for
research which would be of interest to the aviation community.
Statement of the Problem
The FAA prescribes regulations about the acceptable altitudes where a GA pilot
may fly unaided by supplementary oxygen or pressurization. It is apparent that there are
differences between these regulations and other regulations. For example, the
Supplemental Oxygen Rule (2010), which is the guideline for most GA pilots, states that
pilots may fly up to but not including 12,500 feet MSL, without supplementary oxygen.
The Supplemental Oxygen Rule (2010) also states that a pilot may fly between 12,500
feet MSL and 14,000 feet MSL for 30 minutes without supplemental oxygen before
returning to below 12,500 feet MSL, and a pilot must use supplemental oxygen to fly
above 14,000 feet MSL. However, the Aircraft Certification and Equipment
Requirements Rule (2010), for Part 121 carriers, states that crewmembers must be on
supplemental oxygen at all times above 12,000 feet MSL. This is regardless of the period
of time they are above the altitude and notably stricter than the rules prescribed by the
Supplemental Oxygen Rule (2010). The Pilot Requirements: Use of Oxygen Rule (2010)
for Part 135 carriers states that, in the case of unpressurized aircraft, a pilot must use
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oxygen above 10,000 feet MSL through 12,000 feet MSL if longer than 30 minutes in
duration, and at all times above 12,000 feet MSL.
In addition to the differences in the prescribed rules regarding altitude, it is also
suggested that all pilots would be equally affected by low-altitude hypoxia. However, it is
documented by FAA (2011) that pilots have varying tolerances to hypoxia. The
researcher believed there could be issues arising from inconsistencies in the prescribed
rules regarding altitude, and a possibility that some pilots may experience varying
severity of symptoms. It was therefore important to analyze whether and to what extent
an energy beverage could potentially help pilots to cope with the symptoms of hypoxia
when operating at the upper legal limits of the prescribed rules.
Purpose Statement
The purpose of this study was to determine the effects of an energy beverage on
symptoms of hypoxia by simulating the legal flight altitude of 14,000 feet MSL and
exposing subjects to the symptoms of low-altitude hypoxia. The researcher provided the
subjects with energy beverages and a placebo to evaluate whether there were any effects
on possible symptoms of mild hypoxia.
Hypothesis
The following hypothesis was tested: There will be a difference in the effects of
hypoxia between pilots who consumed an energy beverage before completing a simulated
instrument approach at a simulated altitude of 14,000 feet MSL and pilots who did not,
among college students at Embry-Riddle Aeronautical University, Daytona Beach,
Florida Campus.
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Delimitations
The subjects were self-elected students of Embry-Riddle Aeronautical University,
Daytona Beach, Florida campus. The students were between 18-30 years of age and had
maintained a pilot’s license with an instrument rating and at least a second-class medical
certificate at the time of testing.
The researcher exposed the subjects to the simulated upper legal limit of 14,000
feet MSL to enhance the possibility that the symptoms of low-altitude hypoxia would be
present. The subjects remained at the simulated 14,000 feet MSL altitude for the entire
testing phase. The testing phase did not exceed the legal limit of 30 minutes. The
researcher evaluated whether the energy beverage had an effect on the subjects’
performance in respect to lateral deviations, vertical deviations, and airspeed deviations
while performing a simulated instrument approach.
The subjects were limited to performing the simulated flight tasks utilizing the
Frasca™ Mentor Advanced Aviation Training Device (AATD) (Frasca International,
2011). The AATD was used to test the subjects’ performance while flying an instrument
approach in a typical GA aircraft.
The testing was limited to the normobaric High Altitude Lab (HAL). The HAL
was capable of simulating an environment which is consistent with being at 14,000 feet
MSL (Colorado Altitude Training [CAT], 2009).
Limitations and Assumptions
The subjects were required to complete three separate test sessions, in which they
consumed a different beverage each time. The subjects did not know which beverage they
were consuming at each test session; however, they were aware of the range of
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ingredients in all beverages. Subjects were blind to the beverage type to eliminate any
psychological effect on subjects’ performances.
The subjects were also not aware of the altitude that the HAL was simulating. As
previously stated, the experiment never exceeded the altitudes defined by FAA
regulations in the Supplemental Oxygen Rule (2010). The altitude showed a constant
14,000 feet MSL; however, the HAL has a 1-3% level of error, and as such cannot keep
to 14,000 feet MSL constantly (CAT, 2009).
The method of recruiting the subjects did not allow the researcher to select
subjects with similar attributes such as skill and qualification level, height, weight,
gender etc.; therefore, the researcher did not expect to observe a pattern of similar results.
The subjects were given a pre-test survey, and the accuracy of this survey was dependent
on the subjects’ willingness to be honest. It was assumed that the subjects were forthright
in completing the pre-test survey.
It was assumed that the lab technicians were accurate in following the methods
and procedures of research and conducted the experiment the same way for every subject.
It was assumed that the accuracy of the instruments was consistent for all of the tests.
Definitions of Terms
14 CFR § 91 - Section of the CFRs that covers general operations of aircraft in the
Airspace System (General Operating and Flight Rules, 2010)
14 CFR § 121 - Section of the CFRs that covers scheduled air carrier’s operations in the
Airspace System (Operating Requirements: Domestic, Flag, and Supplemental
Operations Rules, 2010).
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14 CFR § 135 - Section of the CFRs that covers non-scheduled air carrier’s operations in
the Airspace System (Operating Requirements: Commuter and On Demand
Operations and Rules Governing Persons On Board Such Aircraft Rules, 2010)
Blood Oxygen Content - A measure of how many O2 molecules are in the blood.
Measured as a percentage of a 100% total (FAA, 2011)
Dot – Unit of measurement used to represent a deviation from the glide slope, equal to
200 feet MSL (FAA, 2011)
Hypobaric - A decrease in atmospheric pressure in relation to normal ambient pressure
(FAA, 2011)
Hypoxia - A state of having less oxygen than required for normal bodily and cognitive
function. (FAA, 2011)
Hypoxic Hypoxia - The effect that is caused by a lack of atmospheric pressure. This lack
of oxygen in the body is due to the inability of the oxygen to cross through the
membrane of the lungs into the blood stream. (FAA, 2011)
Normobaric - Standard Sea Level Pressure in relation to the lab (FAA, 2011)
List of Acronyms
AATD

Advanced Aviation Training Device

AC

Advisory Circular

ADM

Aeronautical Decision Making

AGL

Above Ground Level

AIM

Aeronautical Information Manual

ASMA

Aerospace Medical Association

BPM

Beats Per Minute
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CAT

Colorado Altitude Training

CFR

Code of Federal Regulations

DCS

Decompression Sickness

DoD

Department of Defense

DoT

Department of Transportation

EEG

Electroencephalogram

ERAU

Embry-Riddle Aeronautical University

FAA

Federal Aviation Administration

FAR

Federal Aviation Regulations

GA

General Aviation

GS

Glide Slope

HAL

High Altitude Lab

IAS

Indicated Air Speed

ILS

Instrument Landing System

IRB

Institutional Review Board

MSL

Mean Sea Level

NTSB

National Transportation Safety Board

SL

Sea Level

SpO2

Saturation of Oxyhemoglobin

TUC

Time of Useful Consciousness
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Chapter II
Review of the Relevant Literature
The researcher consulted the regulatory sources to ensure that this research would
be in accordance with regulated pilot rules. The legislation was used to identify rulings
for pilots subjected to an unpressurized environment and without supplemental oxygen,
where hypoxic symptoms may occur. The rules regarding the level of exposure a pilot
may have to a reduced oxygen environment were consulted to ensure that the experiment
would be designed and conducted correctly, thus protecting the subjects from harm and
producing results that would be relevant to potential real life scenarios (Supplemental
Oxygen Rule, 2010).
FAA Regulations
The FAA is the governing body for all aspects of civil aviation in the United States.
The primary responsibility of the FAA is to regulate the Civil Aerospace system in the
US for both domestic and international pilots and aircraft (FAA, 2011). The FAA also
regulates the air traffic control facilities, controls certification for pilots and aircraft, and
promotes safety. The promotion of safety is achieved by reducing risk through
regulations.
The Code of Federal Regulations (CFR) is the framework and codification for the
rules that are published through the Federal Register on behalf of the Executive
Departments of the Federal Government (“Code of Federal Regulations” [CFR], 2010).
The CFRs are sectioned into 50 titles and represent all major departments and agencies
within the FAA. The titles are then divided further into chapters, which are then
subdivided into parts (CFR, 2010).
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For the purpose of this study, the applicable Title 14: Aeronautics and Space was of
interest, in particular, Part 91, the General Operating and Flight Rules (2010). Under
Subpart C, Equipment, Instrument and Certificate Requirements, the rules on operating a
U.S. registered aircraft are specified. The rules found under Part 91, Subpart C, govern
most GA pilots and state that no person may operate outside of these conditions. The
code states:
No person may operate a civil aircraft of U.S. registry—
(1) At cabin pressure altitudes above 12,500 feet MSL up to and including 14,000
feet MSL unless the required minimum flight crew is provided with and uses
supplemental oxygen for that part of the flight at those altitudes that is of more
than 30 minutes duration.
(2) At cabin pressure altitudes above 14,000 feet MSL unless the required
minimum flight crew is provided with and uses supplemental oxygen during the
entire flight time at those altitudes.
(3) At cabin pressure altitudes above 15,000 feet MSL unless each occupant of the
aircraft is provided with supplemental oxygen. (Supplemental Oxygen Rule,
2010).
The ruling for GA is, in fact, more relaxed compared to Part 121, regarding
Supplemental Oxygen: Reciprocating Engine Powered Airplanes Rule (2010) that
governs scheduled air carriers. The effects of hypoxia do not tend to be a problem for
passengers and crew because the aircraft are pressurized; whereas, most GA aircraft do
not operate with a pressurized cabin. For Part 121 operators the guidelines state:
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(1) At cabin pressure altitudes above 10,000 feet MSL up to and including 12,000
feet MSL, oxygen must be provided for, and used by, each member of the flight
crew on flight deck duty, and must be provided for other crewmembers, for that
part of the flight at those altitudes that is of more than 30 minutes duration.
(2) At cabin pressure altitudes above 12,000 feet MSL, oxygen must be provided
for, and used by, each member of the flight crew on flight deck duty, and must be
provided for other crewmembers, during the entire flight time at those altitudes.
(Supplemental Oxygen: Reciprocating Engine Powered Airplanes Rule, 2010, p.
327).
The Supplemental Oxygen: Reciprocating Engine Powered Airplanes Rule (2010)
suggests it may be possible to experience symptoms of hypoxia as low as 10,000 feet
MSL. The same rules are outlined in the Pilots Requirements Rule: Use of Oxygen
(2010) which concerns all those who operate under Part 135. The Pilots Requirements
Rule (2010) states that all pilots of unpressurized aircraft must carry supplemental
oxygen for use when operating above 12,000 feet MSL, or between 10,000 feet MSL to
12,000 feet MSL if longer than 30 minutes. In Part 121 and Part 135, the passengers and
crew are the number one priority for safety, hence the stricter rules. Therefore, the FAA
may feel it necessary to use tighter tolerances despite no immediate danger from a
hypoxic environment.
Hypoxia
The FAA Aeronautical Information Manual (AIM) is published annually by the
Department of Transportation (DOT) as a quick reference guide (FAA, 2011). It covers
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all necessary data required by GA pilots, sports pilots and instructors in an easy-to-findformat. Relevant information is described below.
Symptoms of hypoxia. FAA (2011) provides medical facts for pilots, including
information on hypoxia. It defines hypoxia:
(1) Hypoxia is a state of oxygen deficiency in the body sufficient to impair
functions of the brain and other organs. Hypoxia from exposure to altitude is
due only to the reduced barometric pressure encountered at altitude, for the
concentration of oxygen in the atmosphere remains about the 21 percent from
the ground out to space.
(2) Although deterioration in night vision occurs at cabin pressure altitudes as low
as 5,000 feet, other significant effects of altitude hypoxia usually do not occur
in the normal healthy pilot below 12,000 feet. From 12,000 to 15,000 feet of
altitude, judgment, memory, alertness, coordination and ability to make
calculations are impaired, and headache, drowsiness, dizziness and either a
sense of well being (euphoria) or belligerence occur. The effects appear
following increasingly shorter periods of exposure to increasing altitude. In
fact, pilot performance can seriously deteriorate within 15 minutes at 15,000
feet. (FAA, 2011, p. 922).
The FAA states that the effects of altitude hypoxia are, in fact, due to changes in
barometric pressure and not due to the lack of oxygen in the air, as endorsed by the
Aerospace Medical Association (ASMA) (FAA, 2011).The ASMA is highlighted as
being a resource to help recognize the effects of hypoxia. It advises that pilots undertake
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a physiological training program to become more knowledgeable in recognizing the
symptoms of hypoxia (FAA, 2011).
According to the FAR, the effects can be present as low as 5,000 feet MSL at
night and from 12,000 feet MSL during the day, and that supplemental oxygen should be
carried at these altitudes (FAA, 2011).
The FAA (2011) explains that the symptoms of hypoxia can be more significant
among smokers and if carbon monoxide is inhaled from the exhaust. Other accelerators
of the symptoms can include the presence of small amounts of alcohol in the body,
certain prescription drugs, cabin temperature, colds, fevers, or anxiety (FAA, 2011). The
FAA concludes by stating that the effects of hypoxia are extremely difficult to recognize
without proper training. In order for GA pilots to be fully protected, the FAA suggests
supplemental oxygen be used when operating above 10,000 feet MSL during the day, and
5,000 feet MSL at night (FAA, 2011).
Symptoms of hypoxia are difficult to identify, and it is pertinent to highlight that
the symptoms vary in severity depending on the stage of onset (FAA, 2011). There are
four levels of hypoxia, and each one has a set of symptoms related to the saturation of
oxygen in the body. Darwish (2003) defines the stages as listed in Table 1.
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Table 1
Symptoms of Hypoxia
Stages

Altitude
(thousands
of Feet
MSL)
Symptoms

Indifferent
(99%-95%
O2
saturation)

Complete
Compensatory
(94%-85% O2
saturation)

Partial
Compensatory
(84%-70% O2
saturation)

Critical
(69% and
lower O2
saturation)

0-5

5-11

11-18

Above 18

Decrease
in night
vision

Tingle behind
throat

Impaired vision

Circulatory
failure

Impaired
situational
awareness

Impaired flight
control

Convulsions

Euphoria

Impaired Judgment

Cardiovascular
collapse

Drowsiness

Impaired efficiency

Death

Poor
judgment

Impaired
handwriting
Impaired speech
Decreased
coordination
Decreased
sensation to pain

Decreased memory
Note. Adapted from “Aerospace Medicine: Part 1,” by A.A. Darwish, 2003, The Internet
Journal of Pulmonary Medicine, 3 (2), p. 16.

The stages highlighted by Darwish (2003) are defined as those experienced by an
average healthy pilot. However, as denoted by FAA (2011), individuals have different
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tolerances to hypoxia. As a result, it is assumed that an individual may experience more
severe symptoms at a lower altitude than described in Table 1.
A study to evaluate the effects of hypoxia on pilot performance at GA altitudes
was conducted by the FAA (Nesthus, Rush, & Wreggit, 1997). The purpose of that study
was to analyze whether symptoms of hypoxia were present under the prescribed 12,500
feet MSL, given that individuals can show varying tolerances. Nesthus et al. (1997)
defined hypoxia as “a state of oxygen deficiency in the blood, cells, or tissue of the body
sufficient to cause an impairment of function” (p. 12). Nesthus et al. (1997) noted:
In aviation, a reduction in total atmospheric pressure occurs with increasing
altitude. This change produces a reduction of oxygen partial pressure (PO2) and
hence, a reduction of alveolar Oxygen Pressure and the pressure gradient between
the alveoli and mixed venous blood in the pulmonary capillaries. By breathing the
ambient air of a reduced pressure environment, less oxygen diffuses across the
alveolar-capillary membranes into the blood stream and to the tissues of the body.
(p. 13)
Nesthus et al. (1997) also asserts that the body requires a constant level of oxygen
intake if it is to function correctly, and that the brain uses one-fifth of the oxygen we
consume. This is compared to the fact that the brain only represents 2% of the body’s
total weight (Nesthus et al., 1997).
The brain’s ability to function correctly was analyzed further in a
neurophysiology article relating to the topographic changes due to hypobaric hypoxia at
simulated altitudes (Ozaki, Watanabe, & Suzuki, 1995). Ozaki et al. (1995) tested brain
activity against its sensitivity to oxygen supply by measuring the electrical activity and
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functional state when hypoxic. The results showed that, as altitude increased, the
influences of hypoxia affected the physiological parameters (Ozaki et al., 1995). The
12,000 feet MSL stage results of the experiment were most applicable to the 12,500 feet
MSL upper legal limit (more than 30 minutes) prescribed by the FAA for GA pilots
without the need for supplemental oxygen (FAA, 2011). The results showed the brain’s
cognitive function significantly decreased at 12,000 feet MSL, compared to sea level
(Ozaki et al., 1995). Ozaki et al. suggested that the first stage of hypobaric hypoxia is
caused by suppression of alpha Electroencephalogram (EEG) activity. However, these
effects can be skewed by the pilot’s skill level and tolerances to the effects of hypoxia
(Ozaki et al., 1995), which are further discussed by Fiorica, Burr, and Moses (1977).
Fiorica et al., (1977) explored how pilots can perform vigilance tasks at an equivalent
flight level of 11,500 feet MSL. Despite the results proving to be statistically
insignificant, pulse-oximeter readings taken from the pilots revealed a concerning
saturation in their blood oxygen levels and deterioration in vigilance performance
(Fiorica et al., 1977). However, the nature of the experiment was reported as being too
simple and requiring minimal muscular activity; therefore, it was suggested that the
patterns seen would have been far more severe if the vigilance indicators had been more
sophisticated (Fiorica et al., 1977).
Energy and Sports Beverages
For the purpose of this study, it is important to note that energy and sports
beverages are defined as two separate beverage types as classified by Kotke and Gehrke
(2008). The purpose of an energy drink is to provide the consumer with a burst of energy
via a cocktail of ingredients that stimulate the body to become more alert and active
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(Kotke & Gehrke, 2008). The energy drink is also marketed for mental stimulation
effects as denoted by Amendola, Iannilli, Restuccia, Santini, and Vinci (2004). A sports
drink is targeted at athletes, with a purpose of rehydrating the athlete and replenishing
energy and nutrients lost with sugars, vitamins and minerals (Kotke & Gehrke, 2008).
Core active ingredients in energy beverages. Most energy drinks contain
herbal supplements, such as Guarana, Yerba Mate leaves, Pannax ginseng, ginko biloba,
and milk thistle (Kotke & Gehrke, 2008). The most common active ingredient found in
energy beverages is caffeine, which has various doses based on the exact type and
marketed audience of the product (Kotke & Gehrke, 2008). Typically, the variation of
caffeine ranges from 2.5 mg to 171 mg per fluid ounce (Reissig, Strain, & Griffiths,
2008). Caffeine, a central nervous system stimulant, is claimed to improve alertness and
reaction times (Kotke & Gehrke, 2008). Other studies have shown caffeine increases
long-term athletic performance and improves speed and power output (Reissig et al.,
2008). Additionally, caffeine has been attributed to improving mental function and
efficiency on vigilance tasks (Reissig et al., 2008).
Taurine is the second most commonly found key active ingredient in energy
beverages (Amendola et al., 2004; Kotke & Gehrke, 2008). Taurine lowers the heart rate
and noradrenalin concentration, according to Gershon, Shinar, and Ronen (2009), and is
used in the beverages to balance the caffeine intake. Deixelberger-Fritz, Tischler and
Wolfgang (2003) found that the consumption of a Red Bull® did not raise the subjects’
heart rates, which was attributed to the equilibrium produced from Taurine.
Other ingredients commonly found in energy and sports drinks include
carbohydrate-electrolyte compounds (Amendola et al., 2004; Kotke & Gehrke, 2008).
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The purpose of the carbohydrate-electrolyte compound is to provide a boost of energy to
muscles and improve performance (Amendola et al., 2004). There are 14 common
nutritional factors in these compounds including calories, total carbohydrates, sugars,
sodium, potassium, magnesium, vitamin C, vitamin A, vitamin E, niacin, vitamin B12,
pantothenic acid, and thiamine (Amendola et al., 2004).
The electrolytes found in sports and energy beverages are sodium, potassium, and
magnesium, all of which are lost through perspiration (Amendola et al., 2004). The
metabolic heat that is produced when the body is under stress is shown to be lost by
radiation, conduction, convection and vaporization of water, where evaporation accounts
for 80% of metabolic heat loss (American Dietetic Association, 2000). In addition to
water, sweat also contains substantial amounts of sodium, modest amounts of potassium,
and small amounts of minerals such as iron and calcium (American Dietetic Association,
2000). The benefits of adding sodium to a beverage are outlined by Amendola et al.,
(2004) who stated that sodium plays a key role in the body’s ability to ingest fluid, retain
water, and replenish lost nutrients. The benefits of potassium and magnesium in
beverages are as a supplement, which helps prevent the body from cramping to maintain
optimum muscle performance (Amendola et al., 2004).
Amendola et al. (2004) claim the vitamins in the beverages are beneficial for
energy production and protein metabolism. The vitamins in sports and energy beverages
are most beneficial when the vitamins are not produced naturally to a sufficient level,
typically at times when the body is under increased mental and physical stress (Amendola
et al., 2004). When the body is under increased mental and physical stress, it may show
sub-optimal metabolism and decreased performance (Amendola et al., 2004). Vitamins
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and minerals are also related to the repair function of the body (American Dietetic
Association, 2000). Stresses on the body affect the metabolic pathways, which increase
micronutrient needs (American Dietetic Association, 2000).
B vitamins are also commonly found in high doses in energy beverages
(American Dietetic Association, 2000). The American Dietetic Association (2000) states
that B vitamins have two major functions: the production of energy and the regulation
and production of red blood cells for protein synthesis and tissue repair. Vitamins A, E,
and C, beta-carotene, and selenium help protect the body against oxidative damage
(American Dietetic Association, 2000). At times of elevated mental and physical stress,
oxygen requirements can increase by 10 -15 times; therefore, the body requires large
amounts of B vitamins to handle the stress placed on it (American Dietetic Association,
2000).
Effects of energy beverages. The effects of the ingredients found in energy
drinks have been increased cognitive performance, alertness, mood, and mental
performance (Deixelberger-Fritz et al., 2003). In a study by Deixelberger-Fritz et al.
(2003), the energy drink, Red Bull®, was evaluated. Thirty-two subjects were subjected to
a mental performance test after consuming the energy beverage. The participants
included 24 pilots and 8 non-pilots. The results demonstrated “clear-cut positive effects
of the energy drink on choice reaction time and on the performance in a concentration
test,” at a .05 significance level (Deixelberger-Fritz et al., 2003, p.23). Deixelberger-Fritz
et al. (2003) found that the positive effects were sustained for two hours postconsumption and do not coincide with research based on the consumption of just
caffeine. Therefore, Deixelberger-Fritz et al. (2003) concluded that the effects are
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produced by the cocktail of ingredients found in the energy beverage. The study by
Deixelberger-Fritz et al. (2003) allowed for a wash period of 24 hours to avoid potential
residual effects; however, it was noted that performance was still increased by the pilots
on the second day, which was potentially due to a learning effect.
In another study utilizing energy drinks by Gershon et al. (2009), Red Bull® was
evaluated in a driving simulator scenario to counteract fatigue, and the results produced
positive effects. The results showed that the consumption of the energy beverage prior to
completing a simulated driving task increased subject alertness (Gershon et al., 2009).
The findings by Gershon et al. (2009) suggested that the absorption of caffeine reaches its
maximal blood levels between 30-45 minutes post-consumption. The quick metabolism
of energy beverages is endorsed in a further study by Brain Research (2010) on energy
beverages consumed by sprinters and cyclists. In this study, Brain Research (2010)
claimed that energy beverages take an almost immediate effect, due to a neural pathway
connecting the tongue to muscles. Brain Research (2010) stated that the participants had a
30% increased neural response following the consumption of an energy beverage
compared to the placebo.
There were further positive effects found from consuming an energy beverage as
a countermeasure to fatigue, following another driving scenario-based study by Reyner
and Horne (2002). Reyner and Horne (2002) concluded that the consumption of an
energy beverage was beneficial in reducing sleep-related incidents and improved
subjective concentration. The responsible agents were identified as caffeine and Taurine
in combination (Reyner & Horne, 2002).
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A study testing night-shift workers, completed by Jay, Petrilli, Ferguson, Dawson,
and Lamond (2006), attempted to establish if there were negative residual effects on
subsequent sleep post-consumption of an energy beverage. Jay et al. (2006) concluded
that the consumption of an energy beverage helped the participants' ability to stay alert,
and did not affect the participants' ability to achieve a slow-wave sleep, compared to a
control group. Additionally, sleep-onset latency was not affected.
Two separate studies were conducted by Scholey and Kennedy (2004) and Smit
and Rogers (2002) on mental performance, cognitive, and physiological effects following
the consumption of an energy beverage. Smit and Rodgers (2002) discovered that the
subjects who consumed energy beverages displayed clear-cut positive results on mood
and reaction times. The results showed that there were “energizing, alerting and
revitalizing effects of the two test beverages compared to water” (Smit & Rodgers, 2002,
p. 9). These effects were reported to have lasted the duration of the test session, 100
minutes (Smit & Rodgers, 2002). Smit and Rodgers (2002) also reported that the effects
were present in the participants on an average of 38 minutes post-consumption.
Similarly, Scholey and Kennedy (2004) stated that the subjects demonstrated
improved cognitive performance following the consumption of an energy drink. The
results showed that, in comparison to the placebo, there were improvements in secondary
memory and speed of attention among the subjects (Scholey & Kennedy, 2004). Under
all testing conditions, Scholey and Kennedy (2004) revealed a net improvement in
performance. The study's secondary conclusion stated that the cognition-enhancing
properties of the energy beverage cannot be solely attributed to the caffeine, but more
likely a combination of all of the ingredients (Scholey & Kennedy 2004).
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Normobaric High Altitude Lab
The normobaric HAL is a beneficial tool for pilot training, and as such, the FAA
recognizes it as a training instrument for improving pilot safety (CAT, 2009). The HAL
enables a person to experience the effects of a simulated altitude environment without the
need for decompression, as necessary with a hypobaric chamber (CAT, 2009).
A hypobaric chamber reduces the pressure within it to simulate the environment
of the standard atmosphere at an elevated altitude (CAT, 2009). As a result, the chambers
are often small and are costly to operate due to the pressure requirements. One negative
of hypobaric chambers is that the subjects are at risk of decompression sickness, and
cannot return to work or fly for several hours after testing (CAT, 2009).
As an alternative to the hypobaric chamber, the normobaric HAL is often a
preferable instrument for training, as pilots are able to return to work immediately
without risk of developing decompression sickness, as it retains the same barometric
pressure as sea-level (CAT, 2009). Another alternative to the HAL is the Hypoxic MaskBased system (Self, Mandella, Prinzo, Forster, & Shaffstall, 2010). The mask-basedsystem is a portable device that enables the user to experience a hypoxic environment
through breathing gas with reduced oxygen and increased nitrogen (Self et al., 2010). The
mask has limited side effects, allowing the user to fly almost immediately afterward (Self
et al., 2010). However, some research questions the reliability of the mask as it can affect
the subjects' breathing pattern (Self et al., 2010).
The normobaric HAL was a concept designed by Professor Glen Harmon at
ERAU and to date remains one of a handful in the world (CAT, 2009). The normobaric
HAL uses oxygen scrubbers to remove oxygen from the atmosphere within the lab and
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can simulate up to 30,000 feet MSL without a change in pressure (CAT, 2009). Harmon
states that symptoms observed in the HAL can include “tunnel vision, dizziness, tingling,
fatigue, and loss of coordination;” therefore, the lab is used to help train pilots to
recognize how they are individually affected by a hypoxic environment (CAT, 2009).
Frasca International Mentor Advanced Aviation Training Device
The Frasca International Mentor Advanced Aviation Training Device (AATD) is
an FAA-endorsed fixed position flight simulator (Frasca, 2011). It allows pilots to
experience a glass-cockpit flight arrangement (Frasca, 2011). The Mentor is specifically
designed to allow pilots an opportunity to fly aircraft with advanced avionics equipment
such as the Garmin G1000 suite (Frasca, 2011). The Mentor is fully programmable and
contains a Graphical Instructor Station (GIST) allowing the researcher the ability to set
up any number of flight procedures for the subject to complete (Frasca, 2011). The
accuracy of the Mentor is endorsed by the FAA, specifically in terms of both the FAAapproved AATD and the FAA-approved flight data package (Frasca, 2011).
Pulse Oximeter
The pulse oximeter is an important lab tool, as it allows the researcher the ability
to test the subjects' pulse rate and SpO2% saturation levels; which, when combined, give
the researcher an accurate reading of the subjects' blood oxygen levels (Tremper, 1989).
The ability to read a subject's SpO2% levels and beats per minute (BPM) saturation
levels is of great importance, as it allows the researcher to gauge whether the subject is in
one of the four levels of hypoxia as defined by Darwish, (2003). This is pertinent to both
the study and the safety of the subject. The HAL utilizes the Nonin fingertip pulseoximeter to provide fast and accurate blood oxygen level readings (Nonin, 2011). The
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accuracy of the Nonin Onyx used in the HAL was endorsed by achieving a U.S. Army
and U.S. Air Force aero-medical certification (Nonin, 2011). Nonin (2011) states:
The Onyx is ideal for use in any situation where a fast and accurate reading of
blood oxygen saturation and pulse rate is needed. Never search for a pulse
oximeter or sensor again. The portability and functionality of the Onyx makes it a
valuable tool in any situation where a fast and accurate reading of blood oxygen
saturation and pulse rate is needed. (p. 19)
Summary
Part 91, the General Operating and Flight Rule (2010), states that in an unpressurized cabin a pilot may only fly between 12,500 feet MSL and 14,000 feet MSL for
a maximum of 30 minutes without supplemental oxygen. The General Operating and
Flight Rule (2010) also states that, at altitudes above 14,000 feet MSL, the flight crew
must be provided with and use supplemental oxygen; and at altitudes above 15,000 feet
MSL, every occupant must be provided with supplemental oxygen.
Part 121, the Supplemental Oxygen: Reciprocating Engine Powered Airplane Rule
(2010), states that in an unpressurized cabin, supplemental oxygen must be provided if
operating at altitudes above 10,000 feet MSL, up to and including 12,000 feet MSL for
more than 30 minutes. Part 121, the Supplemental Oxygen: Reciprocating Engine
Powered Airplane Rule (2010), also states that above 12,000 feet MSL each member of
the flight crew must be provided and use supplemental oxygen for the entire flight. Under
Part 135, the Pilots Requirements Rule: Use of Oxygen (2010), states that in
unpressurized aircraft, oxygen must be used at altitudes above 10,000 feet MSL through
12,000 feet MSL if that part of the flight exceeds more than 30 minutes duration; and at
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all times above 12,000 feet MSL. The FAA (2011) states that deterioration in night vision
occurs at altitudes as low as 5,000 feet MSL. The FAA (2011) also states that in normal
healthy pilots at altitudes of 12,000 feet MSL and above, judgment, memory, alertness,
and coordination can be impaired. From 12,000 feet MSL and 15,000 feet MSL, pilots
may also experience drowsiness, dizziness, and euphoria (FAA, 2011). Darwish (2003)
states that there are levels of severity in hypoxia, and that human beings have individual
tolerance levels to a low-altitude hypoxic environment, which can be dependent on their
condition of health.
Energy beverages have proven to be stimulants, which suggests they may have an
effect on pilot performance, and may affect the symptoms found from experiencing a
hypoxic environment. Caffeine is recognized as being the main active ingredient in
energy beverages and can improve alertness, mental function and efficiency in vigilance
tasks (Kotke & Gehrke, 2008). Taurine has been observed to actively lower the heart rate
and stabilize the body’s noradrenalin concentration in times of elevated mental and
physical stress (Gershon et al., 2009). The American Dietetic Association (2000) states
that B-vitamins assist in the body’s production of energy and the regulation and
production of red blood cells. Therefore, in high doses similar to the levels found in
energy beverages, B-vitamins will increase the body’s efficiency in the absorption of
oxygen in times of elevated physical and mental stress (American Dietetic Association,
2000).
The Normobaric HAL provides a safe, accurate environment for the subjects to be
tested in, without the possibility of decompression sickness (CAT, 2009). The Frasca
International Mentor AATD is specifically designed to allow pilots an opportunity to fly
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a GA aircraft with advanced avionics equipment, and allows the operator the capability to
program flight tasks for test purposes (Frasca, 2011). The accuracy of the Mentor AATD
was tested by the FAA, and is approved for use as a pilot training device (Frasca, 2011).
The pulse oximeter meets standards for use by the U.S. Army and Air Force (Nonin,
2011).
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Chapter III
Methodology
Research Approach
The study was an experimental design that analyzed the effects of two energy
beverages plus one placebo beverage against the effects of hypoxia in a group of eleven
subjects. The study included comparative research to evaluate and analyze the subjects'
ability to fly a standard simulated instrument approach based on the variables: vertical
deviations from Glide-Slope (GS), lateral deviations from localizer, and deviations from
the prescribed speed of 100 knots. The subjects were always at a simulated altitude where
oxygen deprivation was present to a level that represented 14,000 feet MSL.
The study aimed to evaluate whether the energy beverages could decrease the
effects of hypoxia, and change the subjects' tolerances to its effects. The altitude
remained the same for all subjects; the independent variables were the energy beverages.
The study was conducted within the HAL. The data was collected from the outputs of the
Frasca International Mentor (AATD) (Frasca, 2011). The subjects were asked to conduct
a simulated standard instrument approach in a typical GA aircraft.
The stimulant beverages contain the following common ingredients:
•

Caffeine - The most common ingredient; it stimulates the central nervous
system giving the body a sense of alertness. It can raise the heart rate to
deliver more oxygen around the body (Kotke & Gehrke, 2008).

•

Taurine - It helps regulate heartbeat, muscle contractions, and regulate
energy levels (Kotke & Gehrke, 2008).

•

Guarana – It increases alertness and energy (Kotke & Gehrke, 2008).
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•

B Vitamins – They help with converting food into energy, and improving
the body's ability to intake oxygen into the blood (American Dietetic
Association, 2000).

•

Sugars – They fuel the body and increase energy (American Dietetic
Association, 2000)

•

The placebo was a naturally flavored carbonated water and had no active
ingredients or stimulants of any kind.

Design and procedures. The experiment was fully outlined and submitted to the
Institutional Review Board (IRB), where approval was required due to the use of human
subjects in the experimentations (IRB Forum, 2011). Appendix A contains the IRB
documentation. Upon approval, the research was advertised to participants on a firstcome, first-served basis. The respondents to the advertisement were all male. The
subjects were subsequently invited to an information presentation where they were
informed of all the possible ingredients found in the energy beverages and the potential
side effects of consuming the beverages. In addition, the subjects were provided with
information about the effects of testing in a reduced-oxygen environment. By providing
the subjects with the potential threats and requirements to participate, the researcher had
an opportunity to screen the participants and disqualify any subjects who could not
tolerate this type of testing. One subject did not qualify. In addition to pre testing, the
subjects were given a briefing on the AATD (Frasca, 2011) and the tasks that they were
required to perform. The subjects were split into groups and each attended three lab
sessions on different days with a minimum 24-hour interval between tests.
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Prior to the test, several pre-test sessions were completed by the researchers who
conducted the experiment. The pre-test sessions enabled a set of procedures to be created,
outlining all of the variables for each scenario and a timetable of the subjects' arrival
times. The pre test session allowed the researchers to become proficient in the operation
of the Mentor AATD and identified the test variables. Appendix D contains the HAL
setup procedures.
The final test design required one researcher to be in the HAL at all times, one
researcher to be directly outside the HAL, and one researcher to be in a pre-briefing
room. The purpose of the researcher in the HAL was to operate the Mentor and to ensure
the safety of the participants at all times. The researcher located directly outside the HAL
was in charge of time management, monitoring the HAL instruments, and administering
the pulse-oximeter tests before the subjects entered the HAL and upon exit from the
HAL. The researcher in the briefing room was in charge of meeting and greeting the
subjects, administering the beverages, managing time for the test sessions and ensuring
they were qualified for testing. Qualification for testing was completed by the researcher,
by ensuring that the subjects correctly completed the Pre Test Survey, the High Altitude
Laboratory Participation Form, and the Medical Clearance Form. Appendix C contains
these forms. The beverages were administered in the order of Red Bull®, Monster®, and
then placebo, for each subject to coincide with test, 1, 2, 3. The approach plates tested
were randomized to ensure no two subjects tested on the same approach plate
consecutively. The subjects were always blind to which beverage they had consumed.
Apparatus and materials. The HAL was used as the main apparatus for
manipulating the altitude. Housed within the HAL, the Mentor AATD was used to

31
conduct the evaluation of a simulated flight task. The data was collected and stored on
USB storage devices for security.
The HAL incorporated recording devices, including video cameras, to record the
data. The researcher and the subjects in the HAL had access to oxygen in the event of an
emergency.
Two energy beverages containing common active ingredients were used. A full
list of the active ingredients can be found in Appendix B. The energy beverages were
contained in unmarked, unidentifiable, sterile containers. The researcher required the
subjects to sign that they had been correctly briefed before the test and that they would
adhere to the rules and procedures of the test.
Instrument Pre Test
The researchers conducted a satisfactory pre test for all instruments utilized in the
experiment. The pre test enabled the researchers to recommend whether the instruments
met the needs of the experiment and to design a set of procedures for each scenario. The
test results were monitored and approved by advising professors, who double-checked for
accuracy and screened for unforeseen anomalies.
Subjects
For the purpose of this study, the experimental sample consisted of students from
Embry-Riddle Aeronautical University, Daytona Beach, Florida Campus. The students in
the sample all held a minimum of a FAA class II medical certificate and a certificated
pilot’s license with instrument rating.
The sample of students were self-selected as respondents to advertisements
within Embry Riddle Aeronautical University. This method of self-selection had been
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identified as being appropriate, as the subjects have no influence on this type of study,
providing they met the outlined requirements. There were 11 qualified students who
volunteered, and they were tested over the course of eight sessions, which were
completed over one week.
Sources of the Data
An initial set of data was collected from the pre-test survey. The survey data
included questions on demographics and subjects’ habits. The survey data was collected
to enable the researcher to decide whether the subject qualified for testing. The survey
questions are found in Appendix B.
Test data was obtained from the output files produced by the Mentor Advanced
AATD. The AATD recorded multiple outputs; however, for the purpose of this
experiment, the researcher collected data on deviation from glide slope (dots), deviation
from localizer (feet MSL) and deviation from target speed (knots). Analysis was
calculated based on the means of each variable.
Further data was collected for descriptive purposes from the subject’s pulse
beats-per-minute (BPM), and blood oxygen levels (SpO2%) . The subjects were asked to
provide a pulse-oximeter reading before entering the HAL and upon exit from the HAL.
Instrument reliability. The instruments were selected to be accurate measures of
the tested variables. However, there were limitations in HAL control software, as the
altitude is accurate to within +/- 300 feet MSL (CAT, 2009). The typical figures relating
to the most common pulse oximeter instruments are ± 2 BPM or ± 2% blood oxygen
levels (Nonin, 2011). The Mentor AATD was rated for accuracy by the FAA and was
regarded as an accurate representation of a true-to-life flight task (Frasca, 2011). The
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survey was utilized to validate the procedures and rules surrounding testing and to
qualify/disqualify subjects, based on the predetermined rules.
Instrument validity. To maintain validity, all tests were administered in the
same way, following the same time schedule. The instruments were calibrated before
testing, and a pre test was conducted by the researchers. At all times, two or more
researchers managed the proceedings by providing cross-checks. All subjects spent the
same maximum amount of time in the HAL, as synchronized by all researchers. All
subjects drank the same quantity of each of the beverages. The beverages were
administered at exactly the same time before entering the HAL for all subjects in all tests.
The pre test survey was completed as fairly as possible and required honesty from the
subjects.
Treatment of the Data
Descriptive statistics. For the pre-test survey, Questions 1, 4, 6, 10, 12 and 14
were nominal data and were described by figures. Questions 5, 7 and 15 of the survey
used the Likert scale and were regarded as interval data; therefore they were described in
bar graphs. Questions 8, 9, 13, 16 and 17 were ordinal data and described by figures.
Questions 2, 11 and 19 were interval data and were described in tables containing mean,
standard deviation, minimum, maximum, and count. Questions 3, 18 and 20 required
either a 100% answer or 0 answer and were described by statements.
The pulse-oximeter output variables were pulse rate (BPM) and oxygen saturation
levels (SpO2%) and were regarded as ratio data which were described in tables
containing the mean, standard deviation, minimum, maximum, and count.
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Data outputs from the Mentor AATD were the variables: deviation from glide
slope, deviation from localizer, and deviation from target speed for each subject and for
each beverage. Deviations were ratio data and were described in tables containing mean,
standard deviation, minimum, maximum, and count.
Hypothesis testing. The data from the Mentor AATD was checked at the source
for errors. The data was manipulated into samples for each variable for each subject. The
evaluated data were made of the previous two minutes leading up to decision height, for
each of the variables and for each participant’s three tests. The Mentor AATD produced
one data output per second (Frasca, 2011). The variables were categorized by beverages
1, 2 and 3, and by approach plates 1, 2, and 3. These are summarized in Appendix E. The
means were calculated for each variable for each category. A repeated-measuresANOVA was calculated for each variable, analyzing each of the beverages, and each of
the approach plates against each other to test for significance.
Pilot Study
The experiment was conducted as a pilot study and will enable further research to
be completed in the HAL concerning this subject. This pilot study investigated the
feasibility of conducting a future project with a larger population.
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Chapter IV
Results
Descriptive Statistics – Pre-Test Questionnaire
Eleven students from Embry Riddle Aeronautical University were given a pre-test
questionnaire before entering the HAL. Figure 1 describes the response to Question 1:
Have you ever been in the HAL or other similar lab?

3
27%

Yes
8
73%

No

Figure 1. Question #1.

Table 2 describes the response to Question 2: How many times have you been in
the Lab?

Table 2
Descriptive Statistics for Question 2
Mean
2.2

SD
1.3

Min
0

Max
3

N
11
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Question 3: Are you a pilot? One-hundred percent answered yes, validating the
requirement.
Figure 2 describes the response to Question 4: What is your highest pilot
certification or rating? (PP = Private Pilot, COM = Commercial Pilot, CME =
Commercial Multi Engine, CFI = Certified Flight Instructor)

7
54.5%
6
5
4
3
18.2%

18.2%

2
9.1%
1
0
PP

COM

CME

CFI

Figure 2. Question #4.

Figure 3 describes the response to Question 5: I am anxious about my HAL
experience today.

37
14
36.4%

36.4%

12
10

27.3%

8
6
4
2
0

0

Agree

Strongly
Agree

0
Strongly
Disagree

Disagree

Neutral

Figure 3. Question #5. Note. Each subject responded three separate times to this question.

Figure 4 describes the response to Question 6: I maintained a balanced diet within
the last 24 hours

10
30%
Yes
No
23
70%

Figure 4. Question #6. Note. Each subject responded three separate times to this question.

Figure 5 describes the response to Question 7: I typically drink caffeine-based
products and/or energy drinks

38
4
27.3%

27.3%

3
18.2%

18.2%

2
9.1%
1

0

Strongly
Disagree

Disagree

Neutral

Agree

Strongly
Agree

Figure 5. Question #7.

Figure 6 describes the response to Question 8: When was your last caffeine-based
product and/or energy drink?

15
33%

16
14

11
33%

12
10
7
21%

8
6
4
2

0
0%

0
0%

0-12 Hrs

13-24 Hrs

0
25-36 Hrs

37-48 Hrs

48 Hrs+

Figure 6. Question #8. Note. Each subject responded three separate times to this question.
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Figure 7 describes the response to Question 9: When was your last meal?

1
3%

2
6%
0-2 Hrs

2-4 Hrs
18
53%

13
38%

4-6 Hrs
6-8 Hrs

8 Hrs+

Figure 7. Question #9. Note. Each subject responded three separate times to this question.

Figure 8 describes the response to Question 10: I got 8 hours or more of sleep last
night.

15
45%

18
55%

Yes
No

Figure 8. Question #10. Note. Each subject responded three separate times to this
question.
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Table 3 describes the response to Question 11: Within the last 7 days, how many
nights did you sleep for 8 hours or more?

Table 3
Descriptive Statistics for Question 11
Mean
SD
Min
Max
N
4.1
2.9
0
7
33
Note: Each subject responded three separate times to this question.

Figure 9 describes the response to Question 12: I typically get 8 hours or more of
sleep nightly.

4
36%
Yes
7
64%

No

Figure 9. Question #12.

Figure 10 describes the response to Question 13: How much sleep did you get
within the last 24 hours?
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12
9
27.27%

10
8

10
30.34%
8
24.24%

6
18.18%

6
4
2

0
0%

0
0%

0
0%

1-2 Hrs

2-3 Hrs

3-4 Hrs

0
4-5 Hrs

6-7 Hrs

7-8 Hrs

8 Hrs+

Figure 10. Question #13. Note. Each subject responded three separate times to this
question.

Figure 11 describes the response to Question 14: I exercised 30 minutes or more within
the last 24 hours.

15
45%

18
55%

Yes
No

Figure 11. Question #14. Note. Each subject responded three separate times to this
question.
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Figure 12 describes the response to Question 15: I typically exercise for at least
30 minutes, three separate times, weekly.

30
90.9%

35
30
25
20
15
10
0
0%

5

3
9.1%

0
0%

0
0%

0
Strongly
Disagree

Disagree

Neutral

Agree

Strongly
Agree

Figure 12. Question #15. Note. Each subject responded three separate times to this
question.

Figure 13 describes the response to Question 16: When did you last exercise?

14
10
30.3%

12

10

13
39.4%

9
27.3%

8
6
4
2
0

1
3%

0
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Figure 13. Question #16. Note. Each subject responded three separate times to this
question.
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Figure 14 describes the response to Question 17: How long did you last exercise
for?
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120 Mins+

Figure 14. Question #17. Note. Each subject responded three separate times to this
question.

For Question 18: How many alcoholic drinks have you consumed within 24
hours? All subjects answered zero, validating the requirement.
Table 4 describes the response to Question 19: How many alcoholic drinks have
you consumed within the last 7 days?

Table 4
Descriptive Statistics for Question 19
Mean
SD
Min
Max
N
3.4
4.6
0
14
33
Note: each subject responded three separate times to this question.
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For Question 20: Do you smoke tobacco? One-hundred percent of the participants
responded “no,” thus validating the requirement.
Descriptive Statistics – Pulse Oximeter Readings
Eleven students from Embry-Riddle Aeronautical University gave pre-test and
post-test Pulse-Oximeter readings that were recorded before entering the HAL and upon
leaving the HAL. Table 5 depicts the Pulse-BPM results.

Table 5
Descriptive Statistics for Pre/Post-Test BPM Recordings

Red Bull

®

Monster®

Placebo

BPM Before Test
BPM After Test
BPM Change
Test Duration (Min)
BPM Before Test
BPM After Test
BPM Change
Test Duration (Min)
BPM Before Test
BPM After Test
BPM Change
Test Duration (Min)

Mean
78.0
93.4
15.4
22.2
91.2
106.2
15.0
19.4
75.9
99.3
23.4
19.2

Table 6 depicts the Oximeter - SpO2 results.

SD
19.1
18.2
19.3
2.8
18.7
10.3
13.5
2.1
11.8
15.2
14.0
2.5

Max Min N
113 53 11
125 69 11
61
-6 11
27
19 11
118 64 11
129 94 11
34 -10 11
24
15 11
100 61 11
118 78 11
52
0 11
25
15 11
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Table 6
Descriptive Statistics for Pre/Post-Test %SpO2 Recordings

Red Bull®

Monster®

Placebo

%SpO2 Before Test
%SpO2 After Test
%SpO2 Change
Test Duration (Min)
%SpO2 Before Test
%SpO2 Test
%SpO2 Change
Test Duration (Min)
%SpO2 Before Test
%SpO2 After Test
%SpO2 Change
Test Duration (Min)

Mean
98.64
87.00
- 11.64
22.18
98.73
89.00
- 9.73
19.36
97.91
86.36
- 11.55
19.18

SD
1.03
3.52
3.47
2.79
1.19
5.06
4.58
2.11
0.83
4.65
4.76
2.52

Max
100
94
-6
27
100
98
-1
24
99
93
-5
25

Min
97
82
-17
19
97
81
-16
15
96
79
-19
15

N
11
11
11
11
11
11
11
11
11
11
11
11

Descriptive Statistics – AATD Performance Output
Eleven students from Embry Riddle Aeronautical University completed three
simulated flight tasks within the HAL, using the Frasca International Mentor AATD. The
flight tasks were simulated Instrument landing System (ILS) approaches at Gainesville,
Jacksonville or St. Augustine. The researcher derived three test variables from core
outputs of the AATD: (a) lateral deviations from localizer in dots (one dot equals 2
degrees) (FAA, 2011), (b) vertical deviations from Glide Slope (GS) in feet MSL, and (c)
indicated airspeed (IAS) deviations from target speed of 100 knots. Table 7 describes the
results.
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Table 7
Descriptive Statistics Displaying AATD Outputs for Gainesville, Jacksonville, or St.
Augustine

Gainesville

Jacksonville

St Augustine

Localizer
Deviations
GS
Deviations
IAS
Deviations
Localizer
Deviations
GS
Deviations
IAS
Deviations
Localizer
Deviations
GS
Deviations
IAS
Deviations

Mean

SD

Min

Max

N

0.68

0.47

0.20

1.67

11

27.22

19.50

11.59

71.87

11

2.46

1.08

1.32

4.64

11

0.50

0.29

0.18

1.17

11

53.35 104.67

8.06

366.44

11

3.61

4.15

0.74

15.34

11

0.53

0.33

0.18

1.02

11

56.96 104.18

8.99

366.44

11

2.16

0.86

4.24

11

1.12

Eleven students from Embry Riddle Aeronautical University completed three
simulated flight tasks within the HAL, using the Frasca International Mentor AATD. The
flight tasks were completed after consuming Red Bull®, Monster®, or a placebo beverage.
The researcher derived three test variables from core outputs of the AATD: Lateral
deviations from localizer in dots (one dot equals 2 degrees) (FAA, 2011); vertical
deviations from (GS) in feet MSL; and indicated airspeed (IAS) deviations from target
speed of 100 knots. Table 8 describes the results.
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Table 8
Descriptive Statistics Displaying AATD Outputs for Red Bull®, Monster®, or a Placebo
Mean
Red Bull®

Monster®

Placebo

SD

Localizer
Deviations 0.69
0.45
GS
Deviations 92.49 136.45
IAS
Deviations 3.43
4.05
Localizer
Deviations 0.50
0.27
GS
Deviations 24.49 18.51
IAS
Deviations 2.61
1.10
Localizer
Deviations 0.52
0.36
GS
Deviations 20.55 14.43
IAS
Deviations 2.19
1.56

Min

Max

N

0.28

1.67

11

13.70

366.44

11

1.00

15.34

11

0.18

1.02

11

8.99

72.34

11

1.02

4.44

11

0.19

1.17

11

8.06

52.12

11

0.74

5.47

11

Hypothesis Testing
Approach plate related to simulated flight task performance. A RepeatedMeasures-ANOVA was calculated to test the null hypothesis – There will be no
differences in simulated flight task performance variables (Localizer deviation, GlideSlope deviation, and Indicated Airspeed deviation) among the approaches selected by
random design at a constant 14,000 feet MSL. Tables 9, 10, and 11 show the results. For
all three measures of performance in the AATD, there were no differences for the
randomized approaches. Therefore, the repeated-measures ANOVA failed to reject the
null hypothesis.
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Table 9
Repeated-Measures ANOVA Comparing Localizer Deviation Between Approaches
Mean
.682
.502
.529

Localizer Deviation Gainesville
Localizer Deviation Jacksonville
Localizer Deviation St Augustine

Effect
Localizer
Deviation

Pillai's
Trace
Wilks'
Lambda
Hotelling's
Trace
Roy's
Largest
Root
a. Exact statistic

Std. Deviation
.471
.293
.327
Error
df
9.000

Sig.
.388

N
11
11
11
Partial
Eta
Squared
.190

Value
.190

F
1.055a

Hypothesis
df
2.000

.810

1.055a

2.000

9.000

.388

.190

.234

1.055a

2.000

9.000

.388

.190

.234

1.055a

2.000

9.000

.388

.190

Table 10
Repeated-Measures ANOVA Comparing Glide-Slope Deviation Between Approaches

Glide-Slope Deviation Gainesville
Glide-Slope Deviation Jacksonville
Glide-Slope Deviation St Augustine

Effect
Glide-Slope
Deviations

Pillai's
Trace
Wilks'
Lambda
Hotelling'
s Trace
Roy's
Largest
Root
a. Exact statistic

Value
F
.172 .935a

Mean
27.217
53.354
56.964

Std. Deviation
19.496
104.668
104.183

Hypothesis
df
2.000

Error
df
9.000

Sig.
.427

N
11
11
11
Partial
Eta
Squared
.172

.828

.935a

2.000

9.000

.427

.172

.208

.935a

2.000

9.000

.427

.172

.208

.935a

2.000

9.000

.427

.172
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Table 11
Repeated-Measures ANOVA Comparing Indicated Airspeed Deviation Between
Approaches

Indicated Airspeed Deviations Gainesville
Indicated Airspeed Deviations Jacksonville
Indicated Airspeed Deviations St Augustine

Effect
Indicated
Pillai's
Airspeed
Trace
Deviations Wilks'
Lambda
Hotelling's
Trace
Roy's
Largest
Root
a. Exact statistic

Mean
2.460
3.610
2.169

Std.
Deviation
1.076
4.150
1.120

N
11
11
11
Partial
Hypothesis Error
Eta
df
df
Sig. Squared
2.00
9.00 0.27
0.25

Value
0.25

F
1.497a

0.75

1.497a

2.00

9.00

0.27

0.25

0.33

1.497a

2.00

9.00

0.27

0.25

0.33

1.497a

2.00

9.00

0.27

0.25

Energy beverage related to simulated flight task performance. A RepeatedMeasures-ANOVA was calculated to test the null hypothesis – There will be no
differences in simulated flight task performance variables (Localizer deviation, GlideSlope deviation, and Indicated Airspeed deviation) among the energy beverages selected
by specified design at a constant 14,000 feet MSL. Tables 12, 13, and 14 show the
results. For all three measures of performance in the AATD, there were no differences for
the specified beverage. Therefore, the repeated-measures-ANOVA failed to reject the
null hypothesis.
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Table 12
Repeated-Measures ANOVA Comparing Localizer Deviation Between Beverages

®

Localizer Deviation Red Bull
Localizer Deviation Monster®
Localizer Deviation Placebo
Effect
Localizer Pillai's
Deviation Trace
Wilks'
Lambda
Hotelling's
Trace
Roy's
Largest
Root
a. Exact statistic

Value
.190

Mean
Std. Deviation
N
.692
.452
11
.504
.274
11
.517
.3622
11
Hypothesis Error
Partial Eta
F
df
df
Sig.
Squared
a
1.056
2.000
9.000
.387
.190

.810

1.056a

2.000

9.000

.387

.190

.235

1.056a

2.000

9.000

.387

.190

.235

1.056a

2.000

9.000

.387

.190

Table 13
Repeated-Measures-ANOVA Comparing Glide-Slope Deviation Between Beverages

Value
.371

F
2.659a

Mean
92.494
24.487
20.554
Hypothesis
df
2.000

.629

2.659a

2.000

9.000

.124

.371

.591

2.659a

2.000

9.000

.124

.371

.591

2.659a

2.000

9.000

.124

.371

Glide-Slope Deviation Red Bull®
Glide-Slope Deviation Monster®
Glide-Slope Deviation Placebo
Effect
Glide-Slope
Deviations

Pillai's
Trace
Wilks'
Lambda
Hotelling's
Trace
Roy's
Largest
Root
a. Exact statistic

Std. Deviation
N
136.453
11
18.512
11
14.426
11
Error
Partial Eta
df
Sig.
Squared
9.000 .124
.371
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Table 14
Repeated-Measures ANOVA Comparing Indicated Airspeed Deviation Between
Beverages

®

Indicated Airspeed Deviation Red Bull
Indicated Airspeed Deviation Monster®
Indicated Airspeed Deviation Placebo

Effect
Indicated
Airspeed
Deviations

a. Exact statistic

Pillai's
Trace
Wilks'
Lambda
Hotelling's
Trace
Roy's
Largest
Root

Mean
3.429
2.609
2.191

Std. Deviation
4.048
1.105
1.564

Sig.
.571

N
11
11
11
Partial
Eta
Squared
.117

9.000

.571

.117

2.000

9.000

.571

.117

2.000

9.000

.571

.117

Hypothesis Error
df
df
2.000
9.000

Value
.117

F
.597a

.883

.597a

2.000

.133

.597a

.133

.597a
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Chapter V
Discussion, Conclusions, and Recommendations
Discussion
This study was designed to see if there was a gain in performance by a set of
subjects, based on the Mentor AATD output variables (lateral deviation, vertical
deviation, and airspeed deviation), during periods of simulated low-altitude hypoxia,
when subjects consumed different energy beverages, including a placebo. The studydesign was developed to provide an analytical pilot study that could supply evidence for a
safety recommendation to pilots who may be exposed to conditions conducive of lowaltitude hypoxia. The population consisted of 11 male pilots who had a minimum of a
private pilot's license with an instrument rating, and at least a second-class medical
certificate.
Localizer deviations. A repeated-measures-ANOVA was calculated to evaluate
effects of the energy beverages and the placebo beverage on subjects’ Mentor AATD
performance outputs. The significance for localizer deviations among the averages of the
subjects revealed (p = .387), based on Pillai’s Trace, as calculated in the repeatedmeasures-ANOVA. The mean following consumption of Red Bull® was .692 with a
standard deviation of .452, which was the greatest value. The second ranked mean value
was following consumption of the placebo with .517, and a standard deviation of .3622.
Consumption of the Monster® produced the lowest mean for lateral deviation with .504,
and a standard deviation of .274.
The researcher suggests that the small significance may be explained by Type 2
error because of the small number of subjects. In addition, the researcher suggests that
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practice effects may have affected the results. Specifically, an explanation for Red Bull®
performing worst for the variable (lateral deviation) was that Red Bull® was the first
beverage all subjects consumed. Therefore, it was the first attempt for all subjects to use
the Mentor AATD. The designed order of beverages was Red Bull®, Monster®, and then
placebo. The mean times per test indicate that subjects performed the task quicker as they
gained experience in the AATD. Red Bull®, the first test, had a mean test time of 22
minutes and 18 seconds; Monster® had a mean test time of 19 minutes and 36 seconds;
and the placebo beverage had a mean test time of 19 minutes and 18 seconds. As the
times decreased with the number of tests completed, the researcher suggests that the
subjects improved in proficiency on the Mentor AATD, which may have inadvertently
skewed results for the placebo. In addition, the subjects spent the longest time in the HAL
on their first test, which was Red Bull®; therefore, the subjects had a longer exposure to
the hypoxic environment, which possibly attributed to decreased performance. It should
be noted that the standard deviation for the placebo was the greatest, followed by Red
Bull® and then Monster®. As the placebo beverage had a larger standard deviation, the
researcher concluded that some subjects performed worse upon consuming the placebo
beverage, based on the Mentor AATD output of lateral deviation, and compared with the
other beverages.
Glide-Slope deviations. The performance variable, GS deviations, had a
significance of (p =.124) based on Pillai’s Trace, as calculated in the repeated-measuresANOVA. The p-value was not statistically significant; however, it was smaller than that
seen with the performance output (lateral deviation) (p = .387).
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The mean value for Red Bull® was greatest with a value of 92.494 and a standard
deviation of 136.453. The mean value for Monster® was 24.487 with a standard deviation
of 18.512. The placebo had a mean of 20.554 and a standard deviation of 14.426.
The Mentor AATD output performance indicator (GS deviation) showed that the
subjects performed best following the consumption of the placebo beverage. However,
the researcher concluded that the results may be conflicted, as the subjects spent the
shortest time in the HAL when completing the placebo simulated test, and would have
been least affected by the reduced oxygen environment. In addition, the subjects were
most practiced on the third run, which may explain why the gap between the means of the
Monster® and the placebo are small compared to the gap between Red Bull® and
Monster®. In addition, the researcher suggests that the small significance may be
explained by Type 2 error, because of the small number of subjects.
Indicated airspeed deviations. The performance variable, indicated airspeed
deviations, showed the least significance (p =.571) based on Pillai’s Trace, as calculated
in the repeated-measures-ANOVA. There were no significant differences among the
three beverages; however, trials with Red Bull® continued to have higher deviations. The
mean value for Red Bull® was again greatest with a value of 3.429 and a standard
deviation of 4.048. The mean value for Monster® was 2.609 with a standard deviation of
1.105. The placebo had a mean of 2.191 and a standard deviation of 1.564.
The Mentor AATD output performance indicator (indicated airspeed deviation)
again showed that the subjects performed best following the consumption of the placebo
beverage. The lack of significance recorded is consistent with Type 2 error, which is
common with a small test population. A pilot study is by design a method of evaluating
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the possibility for further study through preliminary testing with a small population. The
subjects performed worst upon consumption of a Red Bull®. There was again a larger gap
between the performances recorded from the subjects' first test (Red Bull®), compared to
the subjects' second test (Monster®). The gap recorded in performance between test two
(Monster®), and test three (placebo) was minimal.
Pulse-Oximeter. The test data related to the pulse-oximeter was not valid for a
statistical analysis, as the readings were taken outside of the HAL. The readings were
taken outside of the HAL because, if the subjects had been aware of their %SpO2
readings during testing, they could have determined the simulated altitude. The readings
were taken immediately before the subjects entered the HAL and immediately upon
exiting the HAL; and as such, the descriptive statistics highlight some interesting
observations.
Comparing the mean changes in the subjects' heart rates upon consumption of
each beverage, some conclusions can be drawn on the physiological effects of the
beverages on the subjects. The mean increase in heart rate following the consumption of
Red Bull® was 15.4 BPM; the mean increase in heart rate following the consumption of
Monster® was 15 BPM; and the mean increase in heart rate following the consumption of
the placebo was 19.2 BPM. Therefore, the average subject's heart-rate increase was
smallest following the consumption of Monster®, second was Red Bull®, and the greatest
increase followed the consumption of a placebo. An explanation for this may be
attributed to the increasing levels of Taurine found in the energy beverages compared to
the placebo. Taurine has been shown to stabilize a human’s heartbeat when exposed to
elevated levels of stress (Kotke & Gehrke, 2008).
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Comparing the mean changes in the subjects' blood-oxygen levels upon
consumption of each beverage; further conclusions can be drawn. The mean bloodoxygen saturation change for Red Bull® was -11.64 %SpO2, the mean blood-oxygen
saturation change for Monster® was -9.73 %SpO2, and the mean blood-oxygen saturation
change for the placebo was -11.55 %SpO2. Therefore, the average change in the subjects'
blood-oxygen saturation was smaller upon consuming the Monster® energy beverage.
The placebo and the Red Bull® beverages showed close results, with the placebo having
the least saturation. However, it is important to note that the mean time in the HAL
during Red Bull® testing was exactly three minutes longer than that of the placebo.
Therefore, the researcher concluded that the saturation might have been smaller upon
consumption of the Red Bull® if the exposure times were equal.
Conclusions
The analyses of the hypothesis were not significant; however, the descriptive
results were encouraging. The researcher concluded that there were non-significant
differences among the performance indicators upon consumption of the energy beverages
compared to the consumption of the placebo.
The researcher concluded that changes in performance despite being statistically
insignificant might be attributed to an improved concentration and a physiological change
in the body’s ability to absorb oxygen from the air due to the large dose of active
ingredients contained within the beverages (Kotke & Gehrke, 2008). The caffeine
contained within the energy beverages is a central nervous system stimulant and is
designed to improve reaction times and mental function (Reissig et al., 2008).
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The enhanced concentration attributed to the energy beverages might have
produced the increased performance noted in the results. In addition, the high doses of
Taurine found in both energy beverages might have slowed the subjects' heart rates
compared to the placebo (Amendola et al., 2004). An increased heart rate is a symptom of
low altitude hypoxia, as noted by Darwish (2003).
The researcher concluded that the cocktail of B-vitamins found in the energy
beverages might have marginally improved the body's efficiency in absorbing oxygen
from the reduced oxygen environment as reported by American Dietetic Association
(2000). When Taurine and large doses of B-vitamins are combined, the body stabilizes
and improves in efficiency when subjected to increased mental and physical stress. This
is a benefit when the body is in need of more oxygen (Amendola et al., 2004; Kotke &
Gehrke, 2008; Reissig et al., 2008).
The researcher concluded that the Monster® energy beverage had the most potent
effects, as it has twice the active ingredients found in Red Bull® (American Dietetic
Association, 2000). The evidence supporting this statement can be seen in the results
from the repeated-measures-ANOVA for the performance indicator, Localizer
Deviations. The descriptive statistics from the blood-oxygen-saturation recordings
support this statement.
Only a small number of the aviation accidents being reported annually are
attributed to low-altitude hypoxia. However, the potential for pilots to experience lowaltitude hypoxia is a credible danger. The researcher concluded that there was some
supporting evidence that would support conducting further research on this subject, with
an aim of making a safety recommendation to pilots. The researcher concluded that this
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pilot study was affected by Type 2 error where the sample size was too small and results
were likely impacted by practice effects.
Recommendations
The results obtained from the Mentor AATD and the Pulse-Oximeter are
consistent with a pilot study and have produced encouraging signs for further research.
Future research should have a larger population. By testing a minimum of 33 subjects, the
results would not be subject to Type 2 error, as in this study. Typically, a minimum of 33
subjects would have been required to achieve a 0.05 effect size.
The researcher recommends that the design should randomize the energy
beverages as well as the approach plates. By randomizing the energy beverages, the
results would not show indications of a practice effect from the first beverage to the last,
with respect to the subject's proficiency on the Mentor AATD. There was evidence
supporting improvement from the first beverage to the second beverage. In addition, there
was a difference in the time of exposure from the first test to the last, due to practice
effects.
The researcher additionally recommends that the subjects complete several pretest simulation approaches to enable them to have enough time to be proficient in the use
of the Mentor AATD, thus eliminating the differences in exposure time. In addition, there
was evidence from questionnaire question (What is your highest pilot qualification or
rating?) that there were pilots with varied levels of experience. Further research should
group subjects based on experience.

59
The researcher observed that the subjects spent different times consuming the
beverages. In future research the test schedule should be designed to begin the test from
the point of consumption and not from the time the beverage was provided.
The researcher recommends that the pulse-oximeter readings should be used for
analysis. The pulse-oximeter could include a wireless sensor that would send the readings
outside of the HAL, so the subjects are never aware of the readings. The researcher also
suggests that a greater variety of test variables be analyzed from the Mentor AATD data
outputs.
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Dear Cass Howell & Daniel Bull,

The Chair of the IRB has reviewed the revised protocol application for the project
titled, “Effects of Energy Beverages in Counteracting the Symptoms of Mild Hypoxia
at General Aviation Altitudes” to see that it met with all the requirements as written in
the Determination Form as was established at the full IRB Committee meeting. All of
the outstanding issues have been addressed and clearly stated in the application and
Consent Form.

You may begin your data collection. Attached is the Revised Determination Form for
your records. Best of luck in your endeavors.

Teri Vigneau (va new), CRA, MPA
Human Protections Administrator
Pre-Award Manager
Sponsored Programs
(386) 226-717
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Pre-test Survey

Dear participant please complete the following pre-test survey. It is compulsory, and the
reliability of the results is dependent on the accuracy of the answers provided. The questions are
designed to ensure this test is completed as safely as possible. Please circle the most appropriate
option, to the best of your ability even if it means you become exempt from testing. Another test
session can be arranged. This questionnaire studies whether daily habits influence hypoxic
reactions during a HAL exposure and all answers will remain confidential, Circle or fill in the
answers as appropriate. Questions 1,2,3,4,7,12,15 and 20 are only required on the first test
session ~Thank you.
Date:

Time:

HAL Experience:
1. Have you ever been in the HAL or other similar lab?
(Circle one) Yes No
2. How many times have you been in the Lab? 0

1

2

3

4

3. Are you a pilot?
(Circle one) Yes No
4. What is your highest pilot certification or rating?
(Circle one) PP
COM
CME
CFI
5. I am anxious about my HAL experience today.
(Circle one) Strongly Disagree Disagree
Neutral

Agree

Strongly Agree

Eating Habits: A balanced diet is 2,000 calories a day from eight servings of grains, five servings of vegetables and
fruits, three servings of milk or dairy products, two or fewer servings of meat and beans, and three servings of
healthy oils (US Department of Agriculture).
6. I maintained a balanced diet within the last 24 hours.
(Circle one) Yes No
7. I typically drink caffeine-based products and/or energy drinks
(Circle one) Strongly Disagree Disagree
Neutral
Agree

Strongly Agree

8. When was your last caffeine-based product and/or energy drink *
(Circle one) 0-12 Hrs
13-24 Hrs
25-36 Hrs
37-48 Hrs
48 Hrs+
* Note: If you have consumed a caffeine-based product and/or energy drink within 24 hours prior to testing,
you cannot complete the test today
9. When was your last meal?**
(Circle one) 0-2 Hrs 2-4 Hrs 4-6 Hrs 6-8 Hrs 8 Hrs+
**Note: If you have eaten within the past 2 hours, you cannot complete the test today
Sleeping Habits:
10. I got 8 hours or more of sleep last night.
(Circle one) Yes No
11. Within the last 7 days, how many nights did you sleep for 8 hours or more?
(Circle one) 0
1
2
3
4
5
6
7
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12. I typically get 8 hours or more of sleep nightly.
(Circle one) Yes No
13. How much sleep did you get within the last 24 hours?
(Circle one) 1-2 Hrs 2-3 Hrs 3-4 Hrs 4-5 Hrs 6-7 Hrs

7-8 Hrs

8 Hrs+

Exercise Habits:
14. I exercised 30 minutes or more within the last 24 hours. (Circle one) Yes No
15. I typically exercise for at least 30 minutes, three separate times, weekly.
(Circle one) Strongly Disagree
Disagree
Neutral
Agree
Strongly Agree
16. When did you last exercise?
(Circle one) 0-6 Hrs
07-12 Hrs

13-18 Hrs

17. How long did you last exercise for?
(Circle one) <30 Mins
31-60 Mins

19-24 hrs

61-90 Mins

25-36 hrs

91-120 Mins

37 Hrs+

120 Mins+

Drinking Habits: An alcoholic drink is defined as a 12-ounce beer, 8-ounces of malt liquor, 5-ounces of wine, or a
1.5-ounce “shot." (US Department of Agriculture and Health)
18. How many alcoholic drinks have you consumed within 24 hours?(Circle one)
0
1
2
3
4
5
6
7
8
9

10

10+

19. How many alcoholic drinks have you consumed within the last 7 days? (Circle one)
0
1
2
3
4
5
6
7
8
9
10

10+

***Note: If you have consumed an alcoholic beverage within the last 24 hours, you cannot complete the test
today
Smoking Habits:
20. Do you smoke tobacco ****
(Circle one) Yes
No
**** Note: If you smoke tobacco, you cannot complete this study

I ……………………………… declare that the answers given are 100% accurate to the best
of my knowledge, and I understand that the questionnaire has been designed to qualify or
eliminate me from completing the study for the protection of my own safety.
Signed …………………………………

This concludes the questionnaire. Thank you for your time!

70
Appendix C
HAL Medical Screening and Release Forms

71

High Altitude Normobaric Lab
Medical Screening Checklist
Participation in the High Altitude Lab (HAL) is limited to ERAU faculty/ students who are:
1. At least 18 years of age, sophomore standing
2. Are enrolled in or have completed AS 357 Flight Physiology
3. Hold a pilot license with an instrument rating and at least a 2nd class FAA medical
certificate or equivalent.
4. Have no known allergies or sensitivities to the ingredients identified in the list below
Acacia
Milk Thistle extract
Ascorbic Acid
Niacinamide
Aspartame
Pannax ginseng extract
Biloba
Pantothenate
Benzoate
Pantothenic Acid
Berry Juice
Phosphorus
Fruit Juice
Potassium
Caffeine
Pyridoxine
Calcium
Riboflavin
Camitne
Sodium
Camitne Fumarate
Sodium Citrate
D-ribose
Sucrose
Ginkgo Biloba leaf extract
Taurine
Ginseng
Vitamin A
Glucose
Vitamin B2
Glucuronolactone
Vitamin B3
Glycerol Ester of wood rosin
Vitamin B5
Grape seed extract
Vitamin B6
Guarana extract
Vitamin B12
Guarana seed
Vitamin C
Inositol
Vitamin D
L-Arginine
Vitamin E
L-Carnitine
Vitamin K
Maltodextrin
Yerba mate leaf extract
Restrictions: Participation in an altitude chamber flight will not be permitted if the applicant
1. Has a disqualifying beard (Beards are permitted if the individual can form an airtight
oxygen mask seal.)
2. Has donated one unit (500 ml) of blood within 24 hours of the scheduled training
3. Is under the influence of alcohol, sedating or psychotrophic drugs, or has consumed any of
the pre-mentioned within 24 hours prior to the test session.
4. Has any known allergies or sensitivities to the ingredients identified in the beverages
required to be consumed
5. Smokes Tobacco
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6. Has any known sensitivities to being subjected to a mildly hypoxic environment
7. Has eaten within two hours prior to arriving for the test session
8. Has consumed a coffee or energy based product within 24 hours prior to arriving for the
test session
Safety Considerations
Following participation in a high altitude lab flight, the student should not fly solo or as a
primary crewmember for a period of 12 hours.
The use of Chap Stick®, lip-gloss, oil or Vaseline® based make-up is not permitted in the lab
while wearing oxygen masks.
Medical Screening:
For health and safety reasons, you must notify an instructor if you are currently experiencing any
of the symptoms or conditions below:
 _______ Dizziness, fainting spells, unconsciousness or seizures
 _______ Eye or vision trouble (except corrective lens)
 _______ Heart or vascular trouble, or anemia
 _______ Upper respiratory infection, asthma or bronchitis
 _______ Chest pain or shortness of breath
 _______ Diabetes
 _______ Medications not approved for flight
 _______ Recent surgery
 _______ Pregnancy or you have other health concerns
Although unlikely, in some subjects symptoms relating to being in a low oxygen environment
may include, but not be limited to dizziness, nausea, rapid breathing, visual impairment, mental
confusion and poor coordination. Some headaches or nausea may also occur after the normobaric
experience any time above sea level oxygen content. If this occurs, you must tell the
instructor/researcher and the test will be terminated.
Despite being very rare, in some consumers the side effects of consuming the ingredients listed
in the table above can cause dizziness, irritability, nausea, nervousness, jitters, nosebleeds, high
blood pressure, low blood pressure, heart palpitations, breast pain, stuffy nose, restlessness and
sleeping difficulty. Allergic reactions can include; rash, hives, itching, difficulty breathing,
tightness in the chest, swelling of the (mouth, face, lips, or tongue), diarrhoea, shakiness, trouble
sleeping, vomiting. Headaches and fatigue may be experienced from withdrawal.
Note: The beverages provided are off-the-shelf, available to all Americans across all of the
United States with no age restriction
I have read and understand the statements above, declare that I am in good health, and agree to
participate in the high altitude-training lab.
_________________________________________________
_____/_____/__________
Print Name
Date
_______________________________________________
Signature
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HIGH-ALTITUDE LABORATORY PARTICIPATION RELEASE FORM
1. I, ________________________________ (name), hereby acknowledge that I will participate in the
use of a High Altitude Laboratory (“Lab”) on the grounds of Embry-Riddle Aeronautical University
(ERAU) in order to experience and learn about the physiological effects of unpressurized high
altitude aviation. I understand that the effects of such experience may include, but not be limited to
dizziness, nausea, rapid breathing, visual impairment, mental confusion and poor coordination. These
effects are usually temporary, but since each person is different and has their own unique medical
circumstances, I recognize that ERAU makes no representations as to how use of the Lab may affect
me.
1. I agree that I am medically and otherwise fit to participate in the use of the high-altitude laboratory,
and that I am free to decline to participate in any activity I deem too risky, dangerous, or ill-advised.
My use of the Lab shall be conclusive evidence that I am fit and qualified to participate therein.
1. In consideration of permission to use the Lab, I hereby release, discharge, and hold harmless ERAU,
its Trustees, Directors, officers, employees, agents, representatives, and successors in interest
(“indemnified parties”) from any and all claims of whatever kind or nature, including serious bodily
injury or death, for any and all claims, demands, obligations, and liabilities arising from, connected
with, or related to my participation in or use of the laboratory or any activity or event connected
therewith.
1. I agree to defend and indemnify the indemnified parties on demand from any and all related claims,
demands, obligations, and liabilities of whatever kind or nature. Additionally, I will not file, cause to
be filed, participate in, permit, or cooperate with or in any action, claim, or demand against the
indemnified parties for any act or event arising from, connected with, or related to my use of the Lab.
1. Any disputes arising from, related to, or in connection with this release or the activities to which it
pertains shall be exclusively subject to the laws, jurisdiction, and venue of the State of Florida and
County of Volusia. I agree to resolve any disputes between me and ERAU by means of mediation
using a mutually agreed mediator. In the event of a failure of mediation for any reason, I agree that, in
lieu of litigation in a court of law, the dispute shall be resolved by means of binding arbitration in
which each side shall select an arbitrator to serve on an arbitration panel, and those selectees shall
chose a third member of the arbitration panel who shall preside. The arbitration panel shall conduct
the arbitration in accordance with the rules of the American Arbitration Association, and its ruling
shall be final and binding upon the parties. Any part of this agreement that is deemed void or voidable
shall be excised from this agreement and the remaining terms shall remain in full force and effect as
though the excised term had never been included.
Signed: ______________________________________
Participant (print): Date
Witness:
(Printed): Date
ERAU OGC Approved
1-030609-7/000
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Dear participant, for the purpose of this study you will be required to consume three separate
beverages, in the table below is an exhausted list of the potential ingredients found within the
beverages you will be required to consume. Please note that the ingredients listed may not be in
the all of the drinks. Please carefully read the list and declare if you wish to participate in this
Study.
Acacia
Ascorbic Acid
Aspartame
Biloba
Benzoate
Berry Juice
Fruit Juice
Caffeine
Calcium
Camitne
Camitne Fumarate
D-ribose
Ginkgo Biloba leaf extract
Ginseng
Glucose
Glucuronolactone
Glycerol Ester of wood rosin
Grape seed extract
Guarana extract
Guarana seed
Inositol
L-Arginine
L-Carnitine
Maltodextrin

Milk Thistle extract
Niacinamide
Pannax ginseng extract
Pantothenate
Pantothenic Acid
Phosphorus
Potassium
Pyridoxine
Riboflavin
Sodium
Sodium Citrate
Sucrose
Taurine
Vitamin A
Vitamin B2
Vitamin B3
Vitamin B5
Vitamin B6
Vitamin B12
Vitamin C
Vitamin D
Vitamin E
Vitamin K
Yerba mate leaf extract

I ………………………………….. declare that I have no known allergies or sensitivities to any
of the ingredients found in the above list and wish to participate in this study. Initial……………
Please declare if you have any other known food or beverage allergies in the space allocated
below.
……………………………………………………………………………………………….……...
………………………………………………………………………………………………………
………………………………………………………………………………………………………
………………………………………………………………………………………………………
………………………………………………………………………………………………………
Signed
……………………………………………………………………………………………………

75
Appendix D
HAL Setup Procedures

76
HAL set up procedures for Gainesville scenario
1. Turn on all the lights.
2. Open both HAL doors.
3. Between two people carefully carry the chair, located behind the HAL, to the
simulator.
4. Retrieve the Gist laptop from its location behind the simulator.
5. Turn on the Gist Laptop.
6. Turn on the circuit breaker on the side of the simulator, immediately after turning
on the Gist.
7. Wait for the communication channel to be reached, the screen will change colors
until arriving at the default Runway 7L DAB.
8. Follow 172 setup checklists to initiate glass cockpit, ensure cockpit controls are
set up for flight and ready for the scenario to begin.
Flaps – Up
Standby Battery – On
Mixture – Rich
Ignition – Both
Throttle – Full
Parking Brake – In
Trim – Neutral
Standby Static Source – In
Electrical Switches – Off
Fuel Shutoff – In
Master Switch – On
Fuel Selector – Both
Avionics Switch – On
FREEZE – Red Button ON
On MFD – Press ENTER
Gist setup is complete.
9. To setup scenario on Gist laptop, begin on ENVIRONMENT icon. Click on
CONDITIONS tab – set altimeter to 30.00. Click on CLOUDS tab – On the first
layer, select overcast, set top to 10,000 ft, set bottom to 0 feet MSL, select red
stop sign; it changes to green. VERIFY on Gist and Mentor Visual Display.
Click on WINDS tab – consult approach plate and set top level wind 90 degrees
left of the localizer (196 Degrees for GNV), select wind = 10 kts of wind, select
gusts = 10 kts, repeat for second level and ground level, click DONE to confirm.
10. Select the GLOBE Icon, Position to Station – from list select appropriate VOR for
scenario, (Ocala OCF for GNV). Set range from Station to 24.5, set the radial to
017, set the heading to 017, this is the same as the radial, select OK to confirm
options. VERIFY on PFD.
11. Select aircraft ATTITUDE icon, consult approach plate and set initial altitude to
be 1000 ft above the approach fix, (2700 for GNV), set heading to the lead-in
radial, ( 017 for GNV), set pitch and bank to 0 degrees, set airspeed to 110 knots,
select OK to confirm options.
12. On Gist APPROACH display, select the airplane symbol, search for the airport
using the identifier, select the runway to be used, select OK and the airport will
change on the Gist approach display.
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13. The Experimenter must now select the RECORD icon, select the red button.
Ensure that the simulator is recording (time advancing).
14. Set up is complete; now move the subject to the simulator chair with the
appropriate approach plate.
15. The experimenter will now read the subject the ATC command – “On the Ocala
017 radial, descend and maintain 1700 Intercept the localizer, cleared for the ILS
RWY 29 approach, altimeter 30.00, and squawk ………” (Participant number).
16. Tell the subject to press the red pause button and begin the approach.
17. Upon completion, select the RECORD icon, stop the recording, select file in the
popup record window, save the file as participant number and date; select OK to
save on hard drive.
18. In the popup record window, select FILE EXPORT, select the just-saved file
name, Windows Explorer will open, find the external USB, select file copy, and it
will save. When complete select OK, It will ask are you sure you want to quit,
select OK.
19. Now experimenter must reset the simulator controls to flight-ready conditions.
Repeat Steps 8-18 for next subject.
20. When the testing day is concluded, select FILE on the Gist toolbar, shut down
trainer, YES, wait until the lap top is off, close the laptop and stow away behind
the simulator.
21. Now turn off the simulator circuit breaker.
22. Carefully return the chair to the original position behind the HAL.
23. Sweep through the HAL to ensure it is returned to its original condition.
NOTE: If the simulator and the Gist fail to communicate select CTRL ALT DEL and
select turn off the computer, if option is not present, a hard shut down will be ok, but not
advisable.
REPORT HAL Problems to Glenn Harmon, phone: 6-6843
REPORT Gist/Mentor Problems to Tom Haritos, phone: 6-6447
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HAL set up procedures for Jacksonville scenario
1. Turn on all the lights.
2. Open both HAL doors.
3. Between two people carefully carry the chair, located behind the HAL, to the
simulator.
4. Retrieve the Gist laptop from its location behind the simulator.
5. Turn on the Gist Laptop.
6. Turn on the circuit breaker on the side of the simulator, immediately aeer turning
on the Gist.
7. Wait for the communication channel to be reached, the screen will change colors
until arriving at the default Runway 7L DAB.
8. Follow 172 setup checklists to initiate glass cockpit, ensure cockpit controls are
set up for flight and ready for the scenario to begin.
Flaps – Up
Standby Battery – On
Mixture – Rich
Ignition – Both
Throttle – Full
Parking Brake – In
Trim – Neutral
Standby Static Source – In
Electrical Switches – Off
Fuel Shutoff – In
Master Switch – On
Fuel Selector – Both
Avionics Switch – On
FREEZE – Red Button ON
On MFD – Press ENTER
Gist setup is complete.
9. To setup scenario on Gist laptop, begin on ENVIRONMENT icon. Click on
CONDITIONS tab – set altimeter to 30.00. Click on CLOUDS tab – On the first
layer, select overcast, set top to 10,000 ft, set bottom to 0 ft, select red stop sign; it
changes to green. VERIFY on Gist and Mentor Visual Display. Click on
WINDS tab – consult approach plate and set top level wind 90 degrees left of the
localizer (164 degrees for JAX), select wind = 10 kts of wind, select gusts = 10
kts, repeat for second level and ground level, click DONE to confirm.
10. Select the GLOBE Icon, Position to Station – from list select appropriate VOR for
scenario, (Craig CRG for JAX). Set range from Station to 8, set the radial to 006,
set the heading to 006, this is the same as the radial, select OK to confirm options.
VERIFY on PFD.
11. Select aircraft ATTITUDE icon, consult approach plate and set initial altitude to
be 1000 feet MSL above the approach fix, (3000 for JAX), set heading to the
lead-in radial, ( 006 for JAX), set pitch and bank to 0 degrees, set airspeed to 110
knots, select OK to confirm options.
12. On Gist APPROACH display, select the airplane symbol, search for the airport
using the identifier, select the runway to be used, select OK and the airport will
change on the Gist approach display.
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13. The Experimenter must now select the RECORD icon, select the red button.
Ensure that the simulator is recording (time advancing).
14. Set up is complete; now move the subject to the simulator chair with the
appropriate approach plate.
15. The experimenter will now read the subject the ATC command – “On the CRAIG
006 radial, descend and maintain 2000 Feet MSL Intercept the localizer, cleared
for the ILS RWY 25 approach, altimeter 30.00, and squawk ………” (Participant
number).
16. Tell the subject to press the red pause button and begin the approach.
17. Upon completion, select the RECORD icon, stop the recording, select file in the
popup record window, save the file as participant number and date; select OK to
save on hard drive.
18. In the popup record window, select FILE EXPORT, select the just-saved file
name, Windows Explorer will open, find the external USB, select file copy, and it
will save. When complete select OK, It will ask are you sure you want to quit,
select OK.
19. Now experimenter must reset the simulator controls to flight-ready conditions.
Repeat Steps 8-18 for next subject.
20. When the testing day is concluded, select FILE on the Gist toolbar, shut down
trainer, YES, wait until the lap top is off, close the laptop and stow away behind
the simulator.
21. Now turn off the simulator circuit breaker.
22. Carefully return the chair to the original position behind the HAL.
23. Sweep through the HAL to ensure it is returned to its original condition.
NOTE: If the simulator and the Gist fail to communicate select CTRL ALT DEL and
select turn off the computer, if option is not present, a hard shut down will be ok, but not
advisable.
REPORT HAL Problems to Glenn Harmon, phone: 6-6843
REPORT Gist/Mentor Problems to Tom Haritos, phone: 6-6447
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HAL set up procedures for St Augustine scenario
1. Turn on all the lights.
2. Open both HAL doors.
3. Between two people carefully carry the chair, located behind the HAL, to the
simulator.
4. Retrieve the Gist laptop from its location behind the simulator.
5. Turn on the Gist Laptop.
6. Turn on the circuit breaker on the side of the simulator, immediately after turning
on the Gist.
7. Wait for the communication channel to be reached, the screen will change colors
until arriving at the default Runway 7L DAB.
8. Follow 172 setup checklists to initiate glass cockpit, ensure cockpit controls are
set up for flight and ready for the scenario to begin.
Flaps – Up
Standby Battery – On
Mixture – Rich
Ignition – Both
Throttle – Full
Parking Brake – In
Trim – Neutral
Standby Static Source – In
Electrical Switches – Off
Fuel Shutoff – In
Master Switch – On
Fuel Selector – Both
Avionics Switch – On
FREEZE – Red Button ON
On MFD – Press ENTER
Gist setup is complete.
9. To setup scenario on Gist laptop, begin on ENVIRONMENT icon. Click on
CONDITIONS tab – set altimeter to 30.00. Click on CLOUDS tab – On the first
layer, select overcast, set top to 10,000 feet MSL, set bottom to 0 feet MSL, select
red stop sign; it changes to green. VERIFY on Gist and Mentor Visual Display.
Click on WINDS tab – consult approach plate and set top level wind 90 degrees
left of the localizer (222 degrees for SGJ), select wind = 10 kts of wind, select
gusts = 10 kts, repeat for second level and ground level, click DONE to confirm.
10. Select the GLOBE Icon, Position to Station – from list select appropriate VOR for
scenario, (Ormond OMN for SGJ). Set range from Station to 29, set the radial to
354, set the heading to 354; this is the same as the radial, select OK to confirm
options. VERIFY on PFD.
11. Select aircraft ATTITUDE icon, consult approach plate and set initial altitude to
be 1000 feet MSL above the approach fix, (4000 for SGJ), set heading to the leadin radial, ( 354 for SGJ), set pitch and bank to 0 degrees, set airspeed to 110
knots, select OK to confirm options.
12. On Gist APPROACH display, select the airplane symbol, search for the airport
using the identifier, select the runway to be used, select OK and the airport will
change on the Gist approach display.
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13. The Experimenter must now select the RECORD icon, select the red button.
Ensure that the simulator is recording (time advancing).
14. Set up is complete; now move the subject to the simulator chair with the
appropriate approach plate.
15. The experimenter will now read the subject the ATC command – “On the
Ormond 354 radial, descend and maintain 3000 Ft Intercept the localizer, cleared
for the ILS RWY 31 approach, altimeter 30.00, and squawk ………” (Participant
number).
16. Tell the subject to press the red pause button and begin the approach.
17. Upon completion, select the RECORD icon, stop the recording, select file in the
popup record window, save the file as participant number and date; select OK to
save on hard drive.
18. In the popup record window, select FILE EXPORT, select the just-saved file
name, Windows Explorer will open, find the external USB, select file copy, and it
will save. When complete select OK, It will ask are you sure you want to quit,
select OK.
19. Now experimenter must reset the simulator controls to flight-ready conditions.
Repeat Steps 8-18 for next subject.
20. When the testing day is concluded, select FILE on the Gist toolbar, shut down
trainer, YES, wait until the lap top is off, close the laptop and stow away behind
the simulator.
21. Now turn off the simulator circuit breaker.
22. Carefully return the chair to the original position behind the HAL.
23. Sweep through the HAL to ensure it is returned to its original condition.
NOTE: If the simulator and the Gist fail to communicate select CTRL ALT DEL and
select turn off the computer, if option is not present, a hard shut down will be ok, but not
advisable.
REPORT HAL Problems to Glenn Harmon, phone: 6-6843
REPORT Gist/Mentor Problems to Tom Haritos, phone: 6-6447
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Table 15
AATD Output Means for Gainesville

Localizer
Subject Deviations
1
0.425
2
0.812
3
0.368
4
1.671
5
0.608
6
0.334
7
0.278
8
0.201
9
1.285
10
0.480
11
1.044

Glide-Slope
Deviations
34.442
19.917
11.593
13.705
20.417
34.376
14.866
11.877
71.871
14.204
52.115

Gainsville
Airspeed
Deviations
2.143
4.644
1.319
1.759
2.652
2.190
1.489
1.528
4.161
2.764
2.410

Table 16
AATD Output Means for Jacksonville

Localizer
Deviations
Subject
1
0.384
2
0.707
3
0.378
4
0.368
5
0.608
6
0.574
7
0.185
8
0.175
9
1.172
10
0.266
11
0.706

Jacksonville
Glide-Slope Airspeed
Deviations Deviations
11.632
1.760
39.259
4.444
27.587
2.014
8.250
2.444
11.001
1.550
43.600
1.880
14.394
0.860
18.826
3.210
37.843
5.472
8.061
0.737
366.443
15.336
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Table 17
AATD Output Means for St Augustine

Localizer
Subject Deviations
1
0.185
2
0.981
3
0.214
4
0.400
5
0.706
6
0.631
7
0.184
8
0.287
9
0.890
10
0.326
11
1.018

St Augustine
Glide-Slope
Airspeed
Deviations Deviations
14.394
0.860
39.259
2.066
13.865
1.189
8.986
1.016
48.176
2.361
34.376
2.407
14.866
1.964
21.318
3.513
72.337
3.143
17.896
0.998
22.860
4.237

Table 18
AATD Output Means for Red Bull®
Red Bull®

Subject
1
2
3
4
5
6
7
8
9
10
11

Localizer
Deviations
0.425
0.981
0.378
1.671
0.706
0.574
0.278
0.287
1.285
0.326
0.706

GlideSlope
Deviations
34.442
39.259
27.587
13.705
48.176
43.600
14.866
21.318
71.871
17.896
366.443

Airspeed
Deviations
2.143
2.066
2.014
1.759
2.361
1.880
1.489
3.513
4.161
0.998
15.336
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Table 19
AATD Output Means for Monster®

Localizer
Subject Deviations
1
0.384
2
0.707
3
0.368
4
0.400
5
0.608
6
0.334
7
0.184
8
0.175
9
0.890
10
0.480
11
1.018

Glide-Slope
Deviations
11.632
39.259
11.593
8.986
20.417
34.376
14.866
18.826
72.337
14.204
22.860

Monster®
Airspeed
Deviations
1.760
4.444
1.319
1.016
2.652
2.190
1.964
3.210
3.143
2.764
4.237

Table 20
AATD Output Means for Placebo

Localizer
Subject Deviations
1
0.185
2
0.812
3
0.214
4
0.368
5
0.608
6
0.631
7
0.185
8
0.201
9
1.172
10
0.266
11
1.044

Glide-Slope
Deviations
14.394
19.917
13.865
8.250
11.001
34.376
14.394
11.877
37.843
8.061
52.115

Placebo
Airspeed
Deviations
0.860
4.644
1.189
2.444
1.550
2.407
0.860
1.528
5.472
0.737
2.410

